Prelabor Rupture of the Membranes

Clinical Obstetrics. The Fetus & Mother: Third Edition

Volumn , Issue , 2008, Pages 1130-1188

  Santolaya Forgas, Joaquin ^a   Romero, Roberto ^b   Espinoza, Jimmy ^a   Erez, Offer ^c   Friel, Lara A ^a   Kusanovic, Juan Pedro ^c   Bahado Singh, Ray ^a   Nien, Jyh Kae ^b  

^a HUTZEL HOSPITAL   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chorioamniotic membranes; Fetal membranes; Pregnancy; Prelabor membrane rupture; Proteolytic activity

Indexed keywords

EID: 84892107362     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470753293.ch63     Document Type: Chapter

References (560)

1. Keirse MJ, Ohlsson A, Treffers PE, Kanhani HHH. Prelabour rupture of the membranes preterm. In: Chalmers I, Enkin M, Keirse MJ, eds. Effective care in pregnancy and childbirth, Oxford: Oxford University Press; 1989:666.
2. Johnson JW, Daikoku NH, Niebyl JR, et al. Premature rupture of the membranes and prolonged latency. Obstet Gynecol 1981;57:547-556.
3. Hauth JC, Cunningham FG, Whalley PJ. Early labor initiation with oral PGE2 after premature rupture of the membranes at term. Obstet Gynecol 1977;49:523-526.
4. Lange AP, Secher NJ, Nielsen FH, Pedersen GT. Stimulation of labor in cases of premature rupture of the membranes at or near term. A consecutive randomized study of prostaglandin E2-tablets and intravenous oxytocin. Acta Obstet Gynecol Scand 1981;60:207-210.
5. Lebherz TB, Hellman LP, Madding R, et al. Double-blind study of premature rupture of the membranes. a report of 1,896 cases. Am J Obstet Gynecol 1963;87:218-225.
6. Magos AL, Noble MC, Wong TY, Rodeck CH. Controlled study comparing vaginal prostaglandin E2 pessaries with intravenous oxytocin for the stimulation of labour after spontaneous rupture of the membranes. Br J Obstet Gynaecol 1983;90:726-731.
7. Tamsen L, Lyrenas S, Cnattingius S. Premature rupture of the membranes-intervention or not. Gynecol Obstet Invest 1990;29:128-131.
8. van der WD, Venter PF. Management of term pregnancy with premature rupture of the membranes and unfavourable cervix. S Afr Med J 1989;75:54-56.
9. Westergaard JG, Lange AP, Pedersen GT, Secher NJ. Use of oral oxytocins for stimulation of labor in cases of premature rupture of the membranes at term. A randomized comparative study of prostaglandin E2 tablets and demoxytocin resoriblets. Acta Obstet Gynecol Scand 1983;62:111-116.
10. Knudsen FU, Steinrud J. Septicaemia of the newborn, associated with ruptured foetal membranes, discoloured amniotic fluid or maternal fever. Acta Paediatr Scand 1976;65:725-731.
11. Verber IG, Pearce JM, New LC, et al. Prolonged rupture of the fetal membranes and neonatal outcome. J Perinat Med 1989;17:469-476.
12. Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol 2003;101:178-193.
13. Christensen KK, Christensen P, Ingemarsson I, et al. A study of complications in preterm deliveries after prolonged premature rupture of the membranes. Obstet Gynecol 1976;48:670-677.
14. Daikoku NH, Kaltreider DF, Khouzami VA, et al. Premature rupture of membranes and spontaneous preterm labor: maternal endometritis risks. Obstet Gynecol 1982;59:13-20.
15. Fayez JA, Hasan AA, Jonas HS, Miller GL. Management of premature rupture of the membranes. Obstet Gynecol 1978;52: 17-21.
16. Gunn GC, Mishell DR, Jr, Morton DG. Premature rupture of the fetal membranes. A review. Am J Obstet Gynecol 1970;106: 469-483.
17. Sachs M, Baker TH. Spontaneous premature rupture of the membranes. Am J Obstet Gynecol 1967;97:888.
18. Gibbs RS, Blanco JD. Premature rupture of the membranes. Obstet Gynecol 1982;60:671-679.
19. Shubert PJ, Diss E, Iams JD. Etiology of preterm premature rupture of membranes. Obstet Gynecol Clin North Am 1992;19: 251-263.
20. Mercer BM. Preterm premature rupture of the membranes: current approaches to evaluation and management. Obstet Gynecol Clin North Am 2005;32:411-428.
21. Schwarcz R, Belizan JM, Nieto F, et al. Third progress report on the Latin American collaborative study on the effects of late rupture of membranes on labor and the neonate, submitted to the Director of the Pan-American Health Organization (PAHO/WHO) and the participating groups. Montevideo: Latin American Center of Perinatology and Human Development, 1974.
22. Quintero RA, Morales WJ, Kalter CS, et al. Transabdominal intra-amniotic endoscopic assessment of previable premature rupture of membranes. Am J Obstet Gynecol 1998;179:71-76.
23. Bell SC, McParland PC. Fetal membrane rupture. In: Critchley H, Bennett P, Thornton S, eds. Preterm birth. London: RCOG Press; 2004:195-212.
24. Bourne GL. The microscopic anatomy of the human amnion and chorion. Am J Obstet Gynecol 1960;79:1070-1073.
25. Benirschke K, Kaufmann P. Anatomy and pathology of the placental membranes. In: Benirschke K, Kaufman P (eds) Pathology of the human placenta, 3rd edn. New York: Springer-Verlag; 1995:268.
26. Danforth DN, Hull RW. The microscopic anatomy of the fetal membranes with particular reference to the detailed structure of the amnion. Am J Obstet Gynecol 1958;75:536.
27. Luckett WP. Amniogenesis in the early human and rhesus monkey embryos. Anat Rec 1973;175:375.
28. Malak TM, Bell SC. Structural characteristics of term human fetal membranes: a novel zone of extreme morphological alteration within the rupture site. Br J Obstet Gynaecol 1994;101: 375-386.
29. McParland PC, Taylor DJ, Bell SC. Mapping of zones of altered morphology and chorionic connective tissue cellular phenotype in human fetal membranes (amniochorion and decidua) overlying the lower uterine pole and cervix before labor at term. Am J Obstet Gynecol 2003;189:1481-1488.
30. McParland PC, Taylor DJ, Bell SC. Myofibroblast differentiation in the connective tissues of the amnion and chorion of term human fetal membranes-implications for fetal membrane rupture and labour. Placenta 2000;21:44-53.
31. McParland PC, Pringle JH, Bell SC. Tenascin and the fetal membrane wound hypothesis-programming for fetal membrane rupture? Br J Obstet Gynaecol 1998;105:1223-1224.
32. McParland PC, Bell SC, Pringle JH, Taylor DJ. Regional and cellular localization of osteonectin/SPARC expression in connective tissue and cytotrophoblastic layers of human fetal membranes at term. Mol Hum Reprod 2001;7:463-474.
33. Bell SC, Malak TM. Structural and cellular biology of the fetal membranes. In: Elder M, Romero R, Lamont R, eds. Preterm labor. New York: Churchill Livingstone; 1997:401-428.
34. Malak TM, Mullholland G, Bell SC. Structural characteristics and fibronectin synthesis by the intact term fetal membranes covering the cervix. Br J Obstet Gynaecol 1993;100:775.
35. Poppel J. Ueber die Resistenz der Eihaute, ein Beitrag zur Mechanik der Geburt. Monatsschr Geburtsk 1863;6:163.
36. Duncan JN. On a lower limit to the power exerted in the function of parturition. Proc R Soc Edin 1869;6:163.
37. Millar LK, Stollberg J, DeBuque L, Bryant-Greenwood G. Fetal membrane distention: determination of the intrauterine surface area and distention of the fetal membranes preterm and at term. Am J Obstet Gynecol 2000;182:128-134.
38. Parry S, Strauss JF, III. Premature rupture of the fetal membranes. N Engl J Med 1998;338:663-670.
39. Lavery JP, Miller CE, Knight RD. The effect of labor on the rhe-ologic response of chorioamniotic membranes. Obstet Gynecol 1982;60:87-92.
40. Al Zaid NS, Bou-Resli MN, Goldspink G. Bursting pressure and collagen content of fetal membranes and their relation to premature rupture of the membranes. Br J Obstet Gynaecol 1980;87:227-229.
41. Artal R, Sokol RJ, Neuman M, et al. The mechanical properties of prematurely and non-prematurely ruptured membranes. Methods and preliminary results. Am J Obstet Gynecol 1976; 125:655-659.
42. Danforth DN, Mcelin TW, States MN. Studies on fetal membranes. I. Bursting tension. Am J Obstet Gynecol 1953;65:480-490.
43. Maclachlan TB. A method for the investigation of the strength of the fetal membranes. Am J Obstet Gynecol 1965;91:309-313.
44. Meudt R, Meudt E. Rupture of the fetal membranes. An experimental, clinical, and histologic study. Am J Obstet Gynecol 1967;99:562-568.
45. Polishuk WZ, Kohane S, Hadar A. Fetal weight and membrane tensile strength. Am J Obstet Gynecol 1964;88:247-250.
46. Parry-Jones E, Priya S. A study of the elasticity and tension of fetal membranes and of the relation of the area of the gestational sac to the area of the uterine cavity. Br J Obstet Gynaecol 1976;83:205-212.
47. Lavery JP, Miller CE. The viscoelastic nature of chorioamniotic membranes. Obstet Gynecol 1977;50:467-472.
48. Lavery JP, Miller CE. Deformation and creep in the human chorioamniotic sac. Am J Obstet Gynecol 1979;134:366-375.
49. Bou-Resli MN, Al Zaid NS, Ibrahim ME. Full-term and prematurely ruptured fetal membranes. An ultrastructural study. Cell Tissue Res 1981;220:263-278.
50. Ibrahim ME, Bou-Resli MN, Al Zaid NS, Bishay LF. Intact fetal membranes. Morphological predisposal to rupture. Acta Obstet Gynecol Scand 1983;62:481-485.
51. Skinner SJ, Campos GA, Liggins GC. Collagen content of human amniotic membranes: effect of gestation length and premature rupture. Obstet Gynecol 1981;57:487-489.
52. Kanayama N, Terao T, Kawashima Y, et al. Collagen types in normal and prematurely ruptured amniotic membranes. Am J Obstet Gynecol 1985;153:899-903.
53. Evaldson GR, Larsson B, Jiborn H. Is the collagen content reduced when the fetal membranes rupture? A clinical study of term and prematurely ruptured membranes. Gynecol Obstet Invest 1987;24:92-94.
54. Vadillo-Ortega F, Gonzalez-Avila G, Karchmer S, et al. Collagen metabolism in premature rupture of amniotic membranes. Obstet Gynecol 1990;75:84-88.
55. MacDermott RI, Landon CR. The hydroxyproline content of amnion and prelabour rupture of the membranes. Eur J Obstet Gynecol Reprod Biol 2000;92:217-221.
56. Kanayama N, Kamijo H, Terao T, et al. The relationship between trypsin activity in amniotic fluid and premature rupture of membranes. Am J Obstet Gynecol 1986;155:1043-1048.
57. Vadillo-Ortega F, Hernandez A, Gonzalez-Avila G, et al. Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. Am J Obstet Gynecol 1996;174:1371-1376.
58. Lei H, Vadillo-Ortega F, Paavola LG, Strauss JF, III. 92-kDa gelatinase (matrix metalloproteinase-9) is induced in rat amnion immediately prior to parturition. Biol Reprod 1995;53:339-344.
59. Rajabi MR, Dean DD, Woessner JF, Jr. Changes in active and latent collagenase in human placenta around the time of parturition. Am J Obstet Gynecol 1990;163:499-505.
60. Bryant-Greenwood GD, Yamamoto SY. Control of peripartal collagenolysis in the human chorion-decidua. Am J Obstet Gynecol 1995;172:63-70.
61. Artal R, Burgeson RE, Hobel CJ, Hollister D. An in vitro model for the study of enzymatically mediated biomechanical changes in the chorioamniotic membranes. Am J Obstet Gynecol 1979;133:656-659.
62. Rajabi M, Dean DD, Woessner JF, Jr. High levels of serum collagenase in premature labor-a potential biochemical marker. Obstet Gynecol 1987;69:179-186.
63. Draper D, McGregor J, Hall J, et al. Elevated protease activities in human amnion and chorion correlate with preterm premature rupture of membranes. Am J Obstet Gynecol 1995;173:1506-1512.
64. Vadillo-Ortega F, Gonzalez-Avila G, Furth EE, et al. 92-kd type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labor. Am J Pathol 1995;146: 148-156.
65. O'Brien WF, Knuppel RA, Morales WJ, et al. Amniotic fluid alpha 1-antitrypsin concentration in premature rupture of the membranes. Am J Obstet Gynecol 1990;162:756-759.
66. Burgos H, Hsi BL, Yeh CJ, Faulk WP. Plasminogen binding by human amniochorion. A possible factor in premature rupture of membranes. Am J Obstet Gynecol 1982;143:958-963.
67. Jenkins DM, O'Neill M, Mattar M, et al. Degenerative changes and detection of plasminogen in fetal membranes that rupture prematurely. Br J Obstet Gynaecol 1983;90:841-846.
68. Milwidsky A, Hurwitz A, Eckstein L, et al. Proteolytic enzymes in human fetal membranes and amniotic fluid. A comparison of normal and premature ruptured membranes. Enzyme 1985;33: 188-196.
69. McGregor JA, Lawellin D, Franco-Buff A, et al. Protease production by microorganisms associated with reproductive tract infection. Am J Obstet Gynecol 1986;154:109-114.
70. McGregor JA, French JI, Lawellin D, et al. Bacterial protease-induced reduction of chorioamniotic membrane strength and elasticity. Obstet Gynecol 1987;69:167-174.
71. Sbarra AJ, Selvaraj RJ, Cetrulo CL, et al. Infection and phagocytosis as possible mechanisms of rupture in premature rupture of the membranes. Am J Obstet Gynecol 1985;153:38-43.
72. Schoonmaker JN, Lawellin DW, Lunt B, McGregor JA. Bacteria and inflammatory cells reduce chorioamniotic membrane integrity and tensile strength. Obstet Gynecol 1989;74:590-596.
73. Helmig R, Uldbjerg N, Ohlsson K. Secretory leukocyte protease inhibitor in the cervical mucus and in the fetal membranes. Eur J Obstet Gynecol Reprod Biol 1995;59:95-101.
74. Sbarra AJ, Thomas GB, Cetrulo CL, et al. Effect of bacterial growth on the bursting pressure of fetal membranes in vitro. Obstet Gynecol 1987;70:107-110.
75. McGregor JA, Schoonmaker JN, Lunt BD, Lawellin DW. Antibiotic inhibition of bacterially induced fetal membrane weakening. Obstet Gynecol 1990;76:124-128.
76. Woessner JF, Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J 1991;5:2145.
77. Romero R, Ray DA, Sepulveda W, et al. Evidence of active forms of 72 kDa and 92 kDa type IV collagenases in human parturition. 39th Annual Meeting of the Society for Gynecologic Investigation, San Antonio, 1992.
78. Fortunato SJ, Menon R, Lombardi S. Induction of MMP-9 and normal presence of MMP-2, TIMP-1 and 2 in human fetal membranes. 17th Annual Meeting of the Society of Perinatal Obstetricians, Anaheim. Am J Obstet Gynecol 1997;176:1.
79. Parks WC, Mecham RP. Matrix metalloproteinases. San Diego, CA: Academic Press, 1998.
80. Fortunato S, Menon R, Swan K, Baricos W. Presence of extracellular matrix degrading enzymes and tissue inhibitor of metal-loproteinases (TIMP-1) in human fetal membranes. Am J Obstet Gynecol 1995;172:518.
81. Romero R, Gomez R. Helming R, et al. Amniotic fluid elastase and secretory leukocyte protease natural inhibitor during labor, rupture of membranes and intrauterine infection. Scientific Abstr 1994;183:O193.
82. Fortunato SJ, Menon R, Swan K, Baricos W. Expression of matrix degrading enzymes and tissue inhibitors of metallopro-teinases (TIMP) in human fetal membranes. 15th Annual Meeting of the Society of Perinatal Obstetricians, Atlanta. Am J Obstet Gynecol 1995;170.
83. Fortunato SJ, LaFleur B, Menon R. Collagenase-3 (MMP-13) in fetal membranes and amniotic fluid during pregnancy. Am J Reprod Immunol 2003;49:120-125.
84. Maymon E, Romero R, Pacora P, et al. Evidence for the participation of interstitial collagenase (matrix metalloproteinase 1) in preterm premature rupture of membranes. Am J Obstet Gynecol 2000;183:914-920.
85. Maymon E, Romero R, Pacora P, et al. Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, and intrauterine infection. Am J Obstet Gynecol 2000;183:94-99.
86. Maymon E, Romero R, Pacora P, et al. Evidence of in vivo differential bioavailability of the active forms of matrix metallo-proteinases 9 and 2 in parturition, spontaneous rupture of membranes, and intra-amniotic infection. Am J Obstet Gynecol 2000;183:887-894.
87. Maymon E, Romero R, Pacora P, et al. Matrilysin (matrix metalloproteinase 7) in parturition, premature rupture of membranes, and intrauterine infection. Am J Obstet Gynecol 2000;182:1545-1553.
88. Maymon E, Romero R, Pacora P, et al. A role for the 72 kDa gelatinase (MMP-2) and its inhibitor (TIMP-2) in human parturition, premature rupture of membranes and intra-amniotic infection. J Perinat Med 2001;29:308-316.
89. Fortunato SJ, Menon R, Lombardi SJ. MMP/TIMP imbalance in amniotic fluid during PROM: an indirect support for endogenous pathway to membrane rupture. J Perinat Med 1999;27:362-368.
90. Fortunato SJ, Menon R, Ahmed NU, et al. Amniotic fluid concentrations of collagenase-1 and collagenase-3 are increased in polyhydramnios. J Perinat Med 2004;32:122-125.
91. Biggio JR, Jr, Ramsey PS, Cliver SP, et al. Midtrimester amniotic fluid matrix metalloproteinase-8 (MMP-8) levels above the 90th percentile are a marker for subsequent preterm premature rupture of membranes. Am J Obstet Gynecol 2005;192:109-113.
92. Morris SM, Stone PJ. Immunocytochemical study of the degradation of elastic fibers in a living extracellular matrix. J His-tochem Cytochem 1995;43:1145-1153.
93. McDonald JA, Kelley DG. Degradation of fibronectin by human leukocyte elastase. Release of biologically active fragments. J Biol Chem 1980;255:8848-8858.
94. Steadman R, Irwin MH, St John PL, et al. Laminin cleavage by activated human neutrophils yields proteolytic fragments with selective migratory properties. J Leukoc Biol 1993;53:354-365.
95. Gadek JE, Fells GA, Wright DG, Crystal RG. Human neutrophil elastase functions as a type III collagen "collagenase". Biochem Biophys Res Commun 1980;95:1815-1822.
96. Mainardi CL, Hasty DL, Seyer JM, Kang AH. Specific cleavage of human type III collagen by human polymorphonuclear leukocyte elastase. J Biol Chem 1980;255:12006-12010.
97. Bergenfeldt M, Axelsson L, Ohlsson K. Release of neutrophil proteinase 4(3) and leukocyte elastase during phagocytosis and their interaction with proteinase inhibitors. Scand J Clin Lab Invest 1992;52:823-829.
98. Helmig BR, Romero R, Espinoza J, et al. Neutrophil elastase and secretory leukocyte protease inhibitor in prelabor rupture of membranes, parturition and intra-amniotic infection. J Matern Fetal Neonatal Med 2002;12:237-246.
99. Tromp G, Kuivaniemi H, Romero R, et al. Genome-wide expression profiling of fetal membranes reveals a deficient expression of proteinase inhibitor 3 in premature rupture of membranes. Am J Obstet Gynecol 2004;191:1331-1338.
100. Romero R, Chaiworapongsa T, Espinoza J, et al. Fetal plasma MMP-9 concentrations are elevated in preterm premature rupture of the membranes. Am J Obstet Gynecol 2002;187: 1125-1130.
101. Ognjanovic S, Ku TL, Bryant-Greenwood GD. Pre-B-cell colony-enhancing factor is a secreted cytokine-like protein from the human amniotic epithelium. Am J Obstet Gynecol 2005;193: 273-282.
102. Nemeth E, Millar LK, Bryant-Greenwood G. Fetal membrane distention: II. Differentially expressed genes regulated by acute distention in vitro. Am J Obstet Gynecol 2000;182:60-67.
103. Nemeth E, Tashima LS, Yu Z, Bryant-Greenwood GD. Fetal membrane distention: I. Differentially expressed genes regulated by acute distention in amniotic epithelial (WISH) cells. Am J Obstet Gynecol 2000;182:50-59.
104. Jia SH, Li Y, Parodo J, et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 2004;113:1318-1327.
105. Kettritz R, Gaido ML, Haller H, et al. Interleukin-8 delays spontaneous and tumor necrosis factor-alpha-mediated apoptosis of human neutrophils. Kidney Int 1998;53:84-91.
106. Romero R. Prenatal medicine: the child is the father of the man. Prenatal Neonatal Med 1996;1:8-11.
107. Romero R, Espinoza J, Mazor M, Chaiworapongsa T. The preterm parturition syndrome. In: Critchley H, Bennett P, Thornton S, eds. Preterm birth. London: RCOG Press; 2004:28-60.
108. Mercer BM, Goldenberg RL, Meis PJ, et al. The Preterm Prediction Study: prediction of preterm premature rupture of membranes through clinical findings and ancillary testing. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 2000;183:738-745.
109. Weiss JL, Malone FD, Vidaver J, et al. Threatened abortion: a risk factor for poor pregnancy outcome, a population-based screening study. Am J Obstet Gynecol 2004;190:745-750.
110. Yang J, Hartmann KE, Savitz DA, et al. Vaginal bleeding during pregnancy and preterm birth. Am J Epidemiol 2004;160:118-125.
111. Carroll SG, Papaioannou S, Ntumazah IL, et al. Lower genital tract swabs in the prediction of intrauterine infection in preterm prelabour rupture of the membranes. Br J Obstet Gynaecol 1996;103:54-59.
112. Fujimoto T, Parry S, Urbanek M, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. J Biol Chem 2002;277:6296-6302.
113. Ferrand PE, Parry S, Sammel M, et al. A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol Hum Reprod 2002;8:494-501.
114. Wang H, Parry S, Macones G, et al. Functionally significant SNP MMP8 promoter haplotypes and preterm premature rupture of membranes (PPROM). Hum Mol Genet 2004;13: 2659-2669.
115. Kurki T, Sivonen A, Renkonen OV, et al. Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol 1992;80:173-177.
116. Simhan HN, Caritis SN, Krohn MA, Hillier SL. The vaginal inflammatory milieu and the risk of early premature preterm rupture of membranes. Am J Obstet Gynecol 2005;192:213-218.
117. Roberts AK, Monzon-Bordonaba F, Van Deerlin PG, et al. Association of polymorphism within the promoter of the tumor necrosis factor alpha gene with increased risk of preterm premature rupture of the fetal membranes. Am J Obstet Gynecol 1999;180:1297-1302.
118. Macones GA, Parry S, Elkousy M, et al. A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-environment interaction in the etiology of spontaneous preterm birth. Am J Obstet Gynecol 2004;190: 1504-1508.
119. Estrada-Gutierrez G, Zaga V, Gonzalez-Jimenez MA, et al. Initial characterization of the microenvironment that regulates connective tissue degradation in amniochorion during normal human labor. Matrix Biol 2005;24:306-312.
120. Goncalves LF, Chaiworapongsa T, Romero R. Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev 2002;8:3-13.
121. Romero R, Quintero R, Oyarzun E, et al. Intraamniotic infection and the onset of labor in preterm premature rupture of the membranes. Am J Obstet Gynecol 1988;159:661-666.
122. Cassell GH, Davis RO, Waites KB, et al. Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amni-otic fluid at 16-20 weeks of gestation: potential effect on outcome of pregnancy. Sex Transm Dis 1983;10:294-302.
123. Horowitz S, Mazor M, Romero R, et al. Infection of the amni-otic cavity with Ureaplasma urealyticum in the midtrimester of pregnancy. J Reprod Med 1995;40:375-379.
124. Gray DJ, Robinson HB, Malone J, Thomson RB, Jr. Adverse outcome in pregnancy following amniotic fluid isolation of Ure-aplasma urealyticum. Prenat Diagn 1992;12:111-117.
125. Yoon BH, Oh SY, Romero R, et al. An elevated amniotic fluid matrix metalloproteinase-8 level at the time of mid-trimester genetic amniocentesis is a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol 2001;185:1162-1167.
126. Arias F, Rodriquez L, Rayne SC, Kraus FT. Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol 1993;168:585-591.
127. Arias F, Victoria A, Cho K, Kraus F. Placental histology and clinical characteristics of patients with preterm premature rupture of membranes. Obstet Gynecol 1997;89:265-271.
128. Kim YM, Chaiworapongsa T, Gomez R, et al. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol 2002;187:1137-1142.
129. Gomez R, Romero R, Nien JK, et al. Idiopathic vaginal bleeding during pregnancy as the only clinical manifestation of intrauterine infection. J Matern Fetal Neonatal Med 2005;18:31-37.
130. Mackenzie AP, Schatz F, Krikun G, et al. Mechanisms of abruption-induced premature rupture of the fetal membranes: Thrombin enhanced decidual matrix metalloproteinase-3 (stromelysin-1) expression. Am J Obstet Gynecol 2004;191: 1996-2001.
131. Rosen T, Schatz F, Kuczynski E, et al. Thrombin-enhanced matrix metalloproteinase-1 expression: a mechanism linking placental abruption with premature rupture of the membranes. J Matern Fetal Neonatal Med 2002;11:11-17.
132. Stephenson CD, Lockwood CJ, Ma Y, Guller S. Thrombin-dependent regulation of matrix metalloproteinase (MMP)-9 levels in human fetal membranes. J Matern Fetal Neonatal Med 2005;18:17-22.
133. Curry TE, Jr, Osteen KG. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev 2003;24:428-465.
134. Darby MJ, Caritis SN, Shen-Schwarz S. Placental abruption in the preterm gestation: an association with chorioamnionitis. Obstet Gynecol 1989;74:88-92.
135. Naeye RL. Factors that predispose to premature rupture of the fetal membranes. Obstet Gynecol 1982;60:93-98.
136. Evaldson G, Lagrelius A, Winiarski J. Premature rupture of the membranes. Acta Obstet Gynecol Scand 1980;59:385-393.
137. Buchmayer SM, Sparen P, Cnattingius S. Previous pregnancy loss: risks related to severity of preterm delivery. Am J Obstet Gynecol 2004;191:1225-1231.
138. Hassan S, Romero R, Hendler I, et al. A sonographic short cervix as the only clinical manifestation of intra-amniotic infection. J Perinat Med 2006;34:13-19.
139. Rizzo G, Capponi A, Vlachopoulou A, et al. Ultrasonographic assessment of the uterine cervix and interleukin-8 concentrations in cervical secretions predict intrauterine infection in patients with preterm labor and intact membranes. Ultrasound Obstet Gynecol 1998;12:86-92.
140. Hein M, Helmig RB, Schonheyder HC, et al. An in vitro study of antibacterial properties of the cervical mucus plug in pregnancy. Am J Obstet Gynecol 2001;185:586-592.
141. Hein M, Valore EV, Helmig RB, et al. Antimicrobial factors in the cervical mucus plug. Am J Obstet Gynecol 2002;187:137-144.
142. Svinarich DM, Wolf NA, Gomez R, et al. Detection of human defensin 5 in reproductive tissues. Am J Obstet Gynecol 1997;176:470-475.
143. Lind J, Wallenburg HC. Pregnancy and the Ehlers-Danlos syndrome: a retrospective study in a Dutch population. Acta Obstet Gynecol Scand 2002;81:293-300.
144. Peterkofsky B. Ascorbate requirement for hydroxylation and secretion of procollagen: relationship to inhibition of collagen synthesis in scurvy. Am J Clin Nutr 1991;54:1135S-1140S.
145. Casanueva E, Avila-Rosas H, Polo E, et al. Vitamin C status, cervico-vaginal infection and premature rupture of amniotic membranes. Arch Med Res 1995;26(Spec. no.):S149-S152.
146. Barrett BM, Sowell A, Gunter E, Wang M. Potential role of ascorbic acid and beta-carotene in the prevention of preterm rupture of fetal membranes. Int J Vitam Nutr Res 1994;64: 192-197.
147. Harger JH, Hsing AW, Tuomala RE, et al. Risk factors for preterm premature rupture of fetal membranes: a multicenter case-control study. Am J Obstet Gynecol 1990;163:130-137.
148. Spinillo A, Nicola S, Piazzi G, et al. Epidemiological correlates of preterm premature rupture of membranes. Int J Gynaecol Obstet 1994;47:7-15.
149. Ladfors L, Mattsson LA, Eriksson M, Milsom I. Prevalence and risk factors for prelabor rupture of the membranes (PROM) at or near-term in an urban Swedish population. J Perinat Med 2000;28:491-496.
150. Asrat T, Lewis DF, Garite TJ, et al. Rate of recurrence of preterm premature rupture of membranes in consecutive pregnancies. Am J Obstet Gynecol 1991;165:1111-1115.
151. Ekwo EE, Gosselink CA, Moawad A. Unfavorable outcome in penultimate pregnancy and premature rupture of membranes in successive pregnancy. Obstet Gynecol 1992;80:166-172.
152. Ekwo EE, Gosselink CA, Moawad A. Previous pregnancy outcomes and subsequent risk of preterm rupture of amniotic sac membranes. Br J Obstet Gynaecol 1993;100:536-541.
153. Eggers TR, Doyle LW, Pepperell RJ. Premature rupture of the membranes. Med J Aust 1979;1:209-213.
154. Townsend L, Aickin DR, Fraillon JM. Spontaneous premature rupture of the membranes. Aust NZ J Obstet Gynaecol 1966;6:226-235.
155. Meyer MB, Tonascia JA. Maternal smoking, pregnancy complications, and perinatal mortality. Am J Obstet Gynecol 1977;128: 494-502.
156. Williams MA, Mittendorf R, Stubblefield PG, et al. Cigarettes, coffee, and preterm premature rupture of the membranes. Am J Epidemiol 1992;135:895-903.
157. Hadley CB, Main DM, Gabbe SG. Risk factors for preterm premature rupture of the fetal membranes. Am J Perinatol 1990;7:374-379.
158. Adams MM, Read JA, Rawlings JS, et al. Preterm delivery among black and white enlisted women in the United States Army. Obstet Gynecol 1993;81:65-71.
159. Schieve LA, Handler A. Preterm delivery and perinatal death among black and white infants in a Chicago-area perinatal registry. Obstet Gynecol 1996;88:356-363.
160. Meis PJ, Ernest JM, Moore ML. Causes of low birth weight births in public and private patients. Am J Obstet Gynecol 1987;156:1165-1168.
161. Odibo AO, Talucci M, Berghella V. Prediction of preterm premature rupture of membranes by transvaginal ultrasound: features and risk factors in a high-risk population. Ultrasound Obstet Gynecol 2002;20:245-251.
162. Fortunato SJ, Lombardi SJ, Menon R. Racial disparity in membrane response to infectious stimuli: a possible explanation for observed differences in the incidence of prematurity. Community Award Paper. Am J Obstet Gynecol 2004;190:1557-1562.
163. Friel L, Kuivaniemi H, Gomez R, et al. Genetic predisposition for preterm PROM: results of a large candidate-gene association study of mothers and their offspring. Am J Obstet Gynecol 2005;193(6):S17.
164. Naeye RL, Peters EC. Causes and consequences of premature rupture of fetal membranes. Lancet 1980;1:192-194.
165. Mills JL, Harlap S, Harley EE. Should coitus late in pregnancy be discouraged? Lancet 1981;2:136-138.
166. Perkins RP. Sexual behavior and response in relation to complications of pregnancy. Am J Obstet Gynecol 1979;134:498-505.
167. Rayburn WF, Wilson EA. Coital activity and premature delivery. Am J Obstet Gynecol 1980;137:972-974.
168. Ekwo EE, Gosselink CA, Woolson R, et al. Coitus late in pregnancy: risk of preterm rupture of amniotic sac membranes. Am J Obstet Gynecol 1993;168:22-31.
169. Casanueva E, Ripoll C, Tolentino M, et al. Vitamin C supplementation to prevent premature rupture of the chorioamniotic membranes: a randomized trial. Am J Clin Nutr 2005;81:859-863.
170. Wideman GL, Baird GH, Bolding OT. Ascorbic acid deficiency and premature rupture of fetal membranes. Am J Obstet Gynecol 1964;88:592-595.
171. Vadillo OF, Pfeffer BF, Bermejo Martinez ML, et al. [Dietetic factors and premature rupture of fetal membranes. Effect of vitamin C on collagen degradation in the chorioamnion]. Ginecol Obstet Mex 1995;63:158-162.
172. Stuart EL, Evans GS, Lin YS, Powers HJ. Reduced collagen and ascorbic acid concentrations and increased proteolytic susceptibility with prelabor fetal membrane rupture in women. Biol Reprod 2005;72:230-235.
173. Artal R, Burgeson R, Fernandez FJ, Hobel CJ. Fetal and maternal copper levels in patients at term with and without premature rupture of membranes. Obstet Gynecol 1979;53:608-610.
174. Kiilholma P, Gronroos M, Erkkola R, et al. The role of calcium, copper, iron and zinc in preterm delivery and premature rupture of fetal membranes. Gynecol Obstet Invest 1984;17:194-201.
175. Sikorski R, Juszkiewicz T, Paszkowski T. Zinc status in women with premature rupture of membranes at term. Obstet Gynecol 1990;76:675-677.
176. Sibai BM, Villar MA, Bray E. Magnesium supplementation during pregnancy: a double-blind randomized controlled clinical trial. Am J Obstet Gynecol 1989;161:115-119.
177. Villar J, Repke JT. Calcium supplementation during pregnancy may reduce preterm delivery in high-risk populations. Am J Obstet Gynecol 1990;163:1124-1131.
178. Simpson J, Palomaki G, Miner B, et al. Association between adverse perinatal outcomes and serially obtained second and third trimester MSAFP measurements. Am J Obstet Gynecol 1995;173:1742.
179. O'Brien WF, Sternlight D, Torres C, et al. The value of early third-trimester maternal serum alpha-fetoprotein determination. Prenat Diagn 1990;10:183-188.
180. Waller DK, Lustig LS, Cunningham GC, et al. Second-trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death. N Engl J Med 1991;325:6-10.
181. Harlap S, Davies AM. Late sequelae of induced abortion: complications and outcome of pregnancy and labor. Am J Epidemiol 1975;102:217-224.
182. Sagot P, Caroit Y, Winer N, et al. Obstetrical prognosis for carbon dioxide laser conisation of the uterine cervix. Eur J Obstet Gynecol Reprod Biol 1995;58:53-58.
183. Samson SL, Bentley JR, Fahey TJ, et al. The effect of loop elec-trosurgical excision procedure on future pregnancy outcome. Obstet Gynecol 2005;105:325-332.
184. Lenihan JP, Jr. Relationship of antepartum pelvic examinations to premature rupture of the membranes. Obstet Gynecol 1984;63:33-37.
185. McDuffie RS, Jr, Nelson GE, Osborn CL, et al. Effect of routine weekly cervical examinations at term on premature rupture of the membranes: a randomized controlled trial. Obstet Gynecol 1992;79:219-322.
186. Main DM, Gabbe SG, Richardson D, Strong S. Can preterm deliveries be prevented? Am J Obstet Gynecol 1985;151:892-898.
187. Main DM, Richardson DK, Hadley CB, Gabbe SG. Controlled trial of a Preterm Labor Detection program: efficacy and costs. Obstet Gynecol 1989;74:873-877.
188. Holbrook R, Falcon J, Hemass M, et al. Evaluation of the weekly cervical examination in a preterm birth prevention program. Am J Perinatol 1987;4:240.
189. Romero R, Mazor M, Oyarzun E, et al. Is genital colonization with Mycoplasma hominis or Ureaplasma urealyticum associated with prematurity/low birth weight? Obstet Gynecol 1989;73: 532-536.
190. Hillier SL, Nugent RP, Eschenbach DA, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 1995;333:1737-1742.
191. Romero R, Chaiworapongsa T, Kuivaniemi H, Tromp G. Bacterial vaginosis, the inflammatory response and the risk of preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol 2004;190:1509-1519.
192. Carey JC, Klebanoff MA, Hauth JC, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 2000;342:534-540.
193. McDonald H, Brocklehurst P, Parsons J. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2005;CD000262.
194. Regan JA, Chao S, James LS. Premature rupture of membranes, preterm delivery, and group B streptococcal colonization of mothers. Am J Obstet Gynecol 1981;141:184-186.
195. Matorras R, Garcia PA, Omenaca F, et al. Group B streptococcus and premature rupture of membranes and preterm delivery. Gynecol Obstet Invest 1989;27:14-18.
196. Alger LS, Lovchik JC, Hebel JR, et al. The association of Chlamydia trachomatis, Neisseria gonorrhoeae, and group B streptococci with preterm rupture of the membranes and pregnancy outcome. Am J Obstet Gynecol 1988;159:397-404.
197. Newton ER, Clark M. Group B streptococcus and preterm rupture of membranes. Obstet Gynecol 1988;71:198-202.
198. Towers CV, Lewis DF, Asrat T, et al. The effect of colonization with group B streptococci on the latency phase of patients with preterm premature rupture of membranes. Am J Obstet Gynecol 1993;169:1139-1143.
199. Maxwell GL, Watson WJ. Preterm premature rupture of membranes: results of expectant management in patients with cervical cultures positive for group B streptococcus or Neisseria gonorrhoeae. Am J Obstet Gynecol 1992;166:945-949.
200. Regan JA, Klebanoff MA, Nugent RP, et al. Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group. Am J Obstet Gynecol 1996;174:1354-1360.
201. Harrison HR, Alexander ER, Weinstein L, et al. Cervical Chlamydia trachomatis and mycoplasmal infections in pregnancy. Epidemiology and outcomes. JAMA 1983;250:1721-1727.
202. Sweet RL, Landers DV, Walker C, Schachter J. Chlamydia trachomatis infection and pregnancy outcome. Am J Obstet Gynecol 1987;156:824-833.
203. Amstey MS, Steadman KT. Asymptomatic gonorrhea and pregnancy. J Am Vener Dis Assoc 1976;3:14-16.
204. Handsfield HH, Hodson WA, Holmes KK. Neonatal gonococcal infection. I. Orogastric contamination with Neisseria gonorrhoeae. JAMA 1973;225:697-701.
205. Edwards LE, Barrada MI, Hamann AA, Hakanson EY. Gonorrhea in pregnancy. Am J Obstet Gynecol 1978;132:637-641.
206. Minkoff H, Grunebaum AN, Schwarz RH, et al. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol 1984;150:965-972.
207. Klebanoff MA, Carey JC, Hauth JC, et al. Failure of metron-idazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001;345:487-493.
208. Carey JC, Klebanoff MA. Is a change in the vaginal flora associated with an increased risk of preterm birth? Am J Obstet Gynecol 2005;192:1341-1346.
209. Barabas AP. Ehlers-Danlos syndrome associated with prematurity and premature rupture of fetal membranes; possible increase in incidence. Br Med J 1966;2:682-684.
210. Yanagihara T, Ueta M, Hanaoka U, et al. Late second-trimester nonstress test characteristics in preterm delivery before 32 weeks of gestation. Gynecol Obstet Invest 2001;51:32-35.
211. Cox SM, Williams ML, Leveno KJ. The natural history of preterm ruptured membranes: what to expect of expectant management. Obstet Gynecol 1988;71:558-562.
212. Wilson JC, Levy DL, Wilds PL. Premature rupture of membranes prior to term: consequences of nonintervention. Obstet Gynecol 1982;60:601-606.
213. Nelson LH, Anderson RL, O'Shea TM, Swain M. Expectant management of preterm premature rupture of the membranes. Am J Obstet Gynecol 1994;171:350-356.
214. Ananth CV, Oyelese Y, Srinivas N, et al. Preterm premature rupture of membranes, intrauterine infection, and oligohydram-nios: risk factors for placental abruption. Obstet Gynecol 2004;104:71-77.
215. Barfield WD, Tomashek KM, Flowers LM, Iyasu S. Contribution of late fetal deaths to US perinatal mortality rates, 1995-1998. Semin Perinatol 2002;26:17-24.
216. Russell KP, Anderson GV. The aggressive management of ruptured membranes. Am J Obstet Gynecol 1962;83:930-937.
217. Romero R, Sirtori M, Oyarzun E, et al. Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamni-otic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol 1989;161:817-824.
218. Romero R, Mazor M, Morretti R, et al. Infection and labor VII. Microbial invasion of the amniotic cavity in spontaneous rupture of membranes at term. Am J Obstet Gynecol 1992;166: 129..
219. Yoon BH, Romero R, Kim M, et al. Clinical implications of detection of Ureaplasma urealyticum in the amniotic cavity with the polymerase chain reaction. Am J Obstet Gynecol 2000;183: 1130-1137.
220. Vintzileos AM, Campbell WA, Nochimson DJ, et al. Qualitative amniotic fluid volume versus amniocentesis in predicting infection in preterm premature rupture of the membranes. Obstet Gynecol 1986;67:579-583.
221. Gonik B, Bottoms SF, Cotton DB. Amniotic fluid volume as a risk factor in preterm premature rupture of the membranes. Obstet Gynecol 1985;65:456-459.
222. Park JS, Yoon BH, Romero R, et al. The relationship between oligohydramnios and the onset of preterm labor in preterm premature rupture of membranes. Am J Obstet Gynecol 2001;184: 459-462.
223. Akinbi HT, Narendran V, Pass AK, et al. Host defense proteins in vernix caseosa and amniotic fluid. Am J Obstet Gynecol 2004;191:2090-2096.
224. Espinoza J, Chaiworapongsa T, Romero R, et al. Antimicrobial peptides in amniotic fluid: defensins, calprotectin and bacterial/permeability-increasing protein in patients with microbial invasion of the amniotic cavity, intra-amniotic inflammation, preterm labor and premature rupture of membranes. J Matern Fetal Neonatal Med 2003;13:2-21.
225. Otsuki K, Yoda A, Toma Y, et al. Lactoferrin and interleukin-6 interaction in amniotic infection. Adv Exp Med Biol 1998;443:267-271.
226. Sachs BP, Stern CM. Activity and characterization of a low molecular fraction present in human amniotic fluid with broad spectrum antibacterial activity. Br J Obstet Gynaecol 1979;86: 81-86.
227. Soto E, Espinoza J, Kusanovic, JP, et al. A natural anti-microbial agent present in normal amniotic fluid participates in the host response to intra-amniotic infection. Am J Obstet Gynecol 2005;193(6):S169.
228. Averbuch B, Mazor M, Shoham-Vardi I, et al. Intra-uterine infection in women with preterm premature rupture of membranes: maternal and neonatal characteristics. Eur J Obstet Gynecol Reprod Biol 1995;62:25-29.
229. Cotton DB, Hill LM, Strassner HT, et al. Use of amniocentesis in preterm gestation with ruptured membranes. Obstet Gynecol 1984;63:38-43.
230. Coultrip LL, Grossman JH. Evaluation of rapid diagnostic tests in the detection of microbial invasion of the amniotic cavity. Am J Obstet Gynecol 1992;167:1231-1242.
231. Garite TJ, Freeman RK, Linzey EM, Braly P. The use of amnio-centesis in patients with premature rupture of membranes. Obstet Gynecol 1979;54:226-230.
232. Zlatnik FJ, Cruikshank DP, Petzold CR, Galask RP. Amniocen-tesis in the identification of inapparent infection in preterm patients with premature rupture of the membranes. J Reprod Med 1984;29:656-660.
233. Broekhuizen FF, Gilman M, Hamilton PR. Amniocentesis for gram stain and culture in preterm premature rupture of the membranes. Obstet Gynecol 1985;66:316-321.
234. Dudley J, Malcolm G, Ellwood D. Amniocentesis in the management of preterm premature rupture of the membranes. Aust NZ J Obstet Gynaecol 1991;31:331-336.
235. Feinstein SJ, Vintzileos AM, Lodeiro JG, et al. Amniocentesis with premature rupture of membranes. Obstet Gynecol 1986;68: 147-152.
236. Font GE, Gauthier DW, Meyer WJ, et al. Catalase activity as a predictor of amniotic fluid culture results in preterm labor or premature rupture of membranes. Obstet Gynecol 1995;85:656-658.
237. Garite TJ, Freeman RK. Chorioamnionitis in the preterm gestation. Obstet Gynecol 1982;59:539-545.
238. Gauthier DW, Meyer WJ, Bieniarz A. Correlation of amniotic fluid glucose concentration and intraamniotic infection in patients with preterm labor or premature rupture of membranes. Am J Obstet Gynecol 1991;165:1105-1110.
239. Gauthier DW, Meyer WJ. Comparison of gram stain, leukocyte esterase activity, and amniotic fluid glucose concentration in predicting amniotic fluid culture results in preterm premature rupture of membranes. Am J Obstet Gynecol 1992;167:1092-1095.
240. Hazan Y, Mazor M, Horowitz S, et al. The diagnostic value of amniotic fluid Gram stain examination and limulus amebocyte lysate assay in patients with preterm birth. Acta Obstet Gynecol Scand 1995;74:275-280.
241. Romero R, Yoon BH, Mazor M, et al. A comparative study of the diagnostic performance of amniotic fluid glucose, white blood cell count, interleukin-6, and gram stain in the detection of microbial invasion in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 1993;169:839-851.
242. Ablow RC, Driscoll SG, Effmann EL, et al. A comparison of early-onset group B steptococcal neonatal infection and the respiratory-distress syndrome of the newborn. N Engl J Med 1976;294:65-70.
243. Jacobs J, Edwards D, Gluck L. Early-onset sepsis and pneumonia observed as respiratory distress syndrome: assessment of lung maturity. Am J Dis Child 1980;134:766-768.
244. Modanlou HD, Bosu SK, Weller MH. Early onset group B streptococcus neonatal septicemia and respiratory distress syndrome: characteristic features of assisted ventilation in the first 24 hours of life. Crit Care Med 1980;8:716-720.
245. Romero R, Yoon BH, Goncalves LF, et al. The clinical significance of microbial invasion of the amniotic cavity with mycoplasmas in patients with preterm PROM. Fortieth Annual Meeting of the Society for Gynecologic Investigation, March 31-April 3. Scientific Abstr 1993;70:S4.
246. Gauthier DW, Meyer WJ, Bieniarz A. Expectant management of premature rupture of membranes with amniotic fluid cultures positive for Ureaplasma urealyticum alone. Am J Obstet Gynecol 1994;170:587-590.
247. Horowitz S, Mazor M, Horowitz J, et al. Antibodies to Ureaplasma urealyticum in women with intraamniotic infection and adverse pregnancy outcome. Acta Obstet Gynecol Scand 1995;74:132-136.
248. Gomez R, Nien JK, Sepulveda G, et al. Antibiotic treatment of patients with preterm PROM does not eradicate intra-amniotic infection or prevent the development of intra-amniotic inflammation. Am J Obstet Gynecol 2001;185(6):S142.
249. Carroll SG, Ville Y, Greenough A, et al. Preterm prelabour amniorrhexis: intrauterine infection and interval between membrane rupture and delivery. Arch Dis Child Fetal Neonatal Ed 1995;72:F43-F46.
250. Gomez R, Romero R, Ghezzi F, et al. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998;179:194-202.
251. Romero R, Gomez R, Ghezzi F, et al. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998;179:186-193.
252. Romero R, Athayde N, Gomez R, et al. The fetal inflammatory response syndrome is characterized by the outpouring of a potent extracellular matrix degrading enzyme into the fetal circulation. Am J Obstet Gynecol 1998;178:S3.
253. Berry SM, Romero R, Gomez R, et al. Premature parturition is characterized by in utero activation of the fetal immune system. Am J Obstet Gynecol 1995;173:1315-1320.
254. Berry SM, Gomez R, Athayde N, et al. The role of granulocyte colony stimulating factor in the neutrophilia observed in the fetal inflammatory response syndrome. Am J Obstet Gynecol 1998;178:S202.
255. Gomez R, Berry S, Yoon BH, et al. The hematologic profile of the fetus with systemic inflammatory response syndrome. Am J Obstet Gynecol 1998;178:S202.
256. Yoon BH, Romero R, Jun JK, et al. An increase in fetal plasma cortisol but not dehydroepiandrosterone sulfate is followed by the onset of preterm labor in patients with preterm premature rupture of the membranes. Am J Obstet Gynecol 1998;179: 1107-1114.
257. Romero R, Espinoza J, Goncalves LF, et al. Fetal cardiac dysfunction in preterm premature rupture of membranes. J Matern Fetal Neonatal Med 2004;16:146-157.
258. Yoon BH, Jun JK, Romero R, et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997;177:19-26.
259. Yoon BH, Romero R, Park JS, et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000;182:675-681.
260. Yoon BH, Romero R, Jun JK, et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997;177: 825-830.
261. Yoon BH, Romero R, Kim KS, et al. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1999;181:773-779.
262. Kim YM, Kim GJ, Kim MR, et al. Skin: an active component of the fetal innate immune system. Am J Obstet Gynecol 2003;189(6):S74.
263. Pacora P, Chaiworapongsa T, Maymon E, et al. Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med 2002;11:18-25.
264. D'Alquen D, Kramer BW, Seidenspinner S, et al. Activation of umbilical cord endothelial cells and fetal inflammatory response in preterm infants with chorioamnionitis and funisitis. Pediatr Res 2005;57:263-269.
265. Yoon BH, Romero R, Park JS, et al. The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol 2000;183:1124-1129.
266. Wu YW, Colford JM, Jr. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 2000;284:1417-1424.
267. Leviton A, Paneth N, Reuss ML, et al. Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants. Developmental Epidemiology Network Investigators. Pediatr Res 1999;46:566-575.
268. Cornette L. Fetal and neonatal inflammatory response and adverse outcome. Semin Fetal Neonatal Med 2004;9:459-470.
269. Pankuch GA, Appelbaum PC, Lorenz RP, et al. Placental microbiology and histology and the pathogenesis of chorioamnionitis. Obstet Gynecol 1984;64:802-806.
270. Romero R, Salafia CA, Athanassiadis AP, et al. The relationship between acute inflammatory lesions of the preterm placenta and amniotic fluid microbiology. Am J Obstet Gynecol 1992;166: 1382..
271. Ananth CV, Savitz DA, Williams MA. Placental abruption and its association with hypertension and prolonged rupture of membranes: a methodologic review and meta-analysis. Obstet Gynecol 1996;88:309-318.
272. Ananth CV, Smulian JC, Demissie K, et al. Placental abruption among singleton and twin births in the United States: risk factor profiles. Am J Epidemiol 2001;153:771-778.
273. Nelson DM, Stempel LE, Zuspan FP. Association of prolonged, preterm premature rupture of the membranes and abruptio placentae. J Reprod Med 1986;31:249-253.
274. Vintzileos AM, Campbell WA, Nochimson DJ, Weinbaum PJ. Preterm premature rupture of the membranes: a risk factor for the development of abruptio placentae. Am J Obstet Gynecol 1987;156:1235-1238.
275. Gonen R, Hannah ME, Milligan JE. Does prolonged preterm premature rupture of the membranes predispose to abruptio placentae? Obstet Gynecol 1989;74:347-350.
276. Major CA, de Veciana M, Lewis DF, Morgan MA. Preterm premature rupture of membranes and abruptio placentae: is there an association between these pregnancy complications? Am J Obstet Gynecol 1995;172:672-676.
277. Naeye RL. Coitus and antepartum haemorrhage. Br J Obstet Gynaecol 1981;88:765-770.
278. Lockwood CJ, Toti P, Arcuri F, et al. Mechanisms of abruption-induced premature rupture of the fetal membranes: thrombin-enhanced interleukin-8 expression in term decidua. Am J Pathol 2005;167:1443-1449.
279. Lauria MR, Gonik B, Romero R. Pulmonary hypoplasia: pathogenesis, diagnosis, and antenatal prediction. Obstet Gynecol 1995;86:466-475.
280. Rotschild A, Ling EW, Puterman ML, Farquharson D. Neonatal outcome after prolonged preterm rupture of the membranes. Am J Obstet Gynecol 1990;162:46-52.
281. Vergani P, Ghidini A, Locatelli A, et al. Risk factors for pulmonary hypoplasia in second-trimester premature rupture of membranes. Am J Obstet Gynecol 1994;170:1359-1364.
282. Moessinger AC, Collins MH, Blanc WA, et al. Oligohydramnios-induced lung hypoplasia: the influence of timing and duration in gestation. Pediatr Res 1986;20:951-954.
283. Winn HN, Chen M, Amon E, et al. Neonatal pulmonary hypoplasia and perinatal mortality in patients with midtrimester rupture of amniotic membranes-a critical analysis. Am J Obstet Gynecol 2000;182:1638-1644.
284. Johnson A, Callan NA, Bhutani VK, et al. Ultrasonic ratio of fetal thoracic to abdominal circumference: an association with fetal pulmonary hypoplasia. Am J Obstet Gynecol 1987;157: 764-769.
285. Nimrod C, Varela-Gittings F, Machin G, et al. The effect of very prolonged membrane rupture on fetal development. Am J Obstet Gynecol 1984;148:540-543.
286. Thibeault DW, Beatty EC, Jr, Hall RT, et al. Neonatal pulmonary hypoplasia with premature rupture of fetal membranes and oligohydramnios. J Pediatr 1985;107:273-277.
287. Blott M, Greenough A, Nicolaides KH, et al. Fetal breathing movements as predictor of favourable pregnancy outcome after oligohydramnios due to membrane rupture in second trimester. Lancet 1987;2:129-131.
288. Moessinger AC, Fox HE, Higgins A, et al. Fetal breathing movements are not a reliable predictor of continued lung development in pregnancies complicated by oligohydramnios. Lancet 1987;2:1297-1300.
289. Harding R, Sigger JN, Wickham PJ, Bocking AD. The regulation of flow of pulmonary fluid in fetal sheep. Respir Physiol 1984;57:47-59.
290. Badalian SS, Chao CR, Fox HE, Timor-Tritsch IE. Fetal breathing-related nasal fluid flow velocity in uncomplicated pregnancies. Am J Obstet Gynecol 1993;169:563-567.
291. Adzick NS, Harrison MR, Glick PL, et al. Experimental pulmonary hypoplasia and oligohydramnios: relative contributions of lung fluid and fetal breathing movements. J Pediatr Surg 1984;19:658-665.
292. Alcorn D, Adamson TM, Lambert TF, et al. Morphological effects of chronic tracheal ligation and drainage in the fetal lamb lung. J Anat 1977;123:649-660.
293. Fewell JE, Hislop AA, Kitterman JA, Johnson P. Effect of tra-cheostomy on lung development in fetal lambs. J Appl Physiol 1983;55:1103-1108.
294. Wigglesworth JS, Desai R, Hislop AA. Fetal lung growth in congenital laryngeal atresia. Pediatr Pathol 1987;7:515-525.
295. Nicolini U, Fisk NM, Rodeck CH, et al. Low amniotic pressure in oligohydramnios-is this the cause of pulmonary hypoplasia? Am J Obstet Gynecol 1989;161:1098-1101.
296. Nimrod C, Davies D, Iwanicki S, et al. Ultrasound prediction of pulmonary hypoplasia. Obstet Gynecol 1986;68:495-498.
297. Songster GS, Gray DL, Crane JP. Prenatal prediction of lethal pulmonary hypoplasia using ultrasonic fetal chest circumference. Obstet Gynecol 1989;73:261-266.
298. Fong K, Ohlsson A, Zalev A. Fetal thoracic circumference: a prospective cross-sectional study with real-time ultrasound. Am J Obstet Gynecol 1988;158:1154-1160.
299. D'Alton M, Mercer B, Riddick E, Dudley D. Serial thoracic versus abdominal circumference ratios for the prediction of pulmonary hypoplasia in premature rupture of the membranes remote from term. Am J Obstet Gynecol 1992;166:658-663.
300. Ohlsson A, Fong K, Rose T, et al. Prenatal ultrasonic prediction of autopsy-proven pulmonary hypoplasia. Am J Perinatol 1992;9:334-337.
301. Roberts AB, Mitchell JM. Direct ultrasonographic measurement of fetal lung length in normal pregnancies and pregnancies complicated by prolonged rupture of membranes. Am J Obstet Gynecol 1990;163:1560-1566.
302. Fox HE, Badalian SS, Timor-Tritsch IE, et al. Fetal upper respiratory tract function in cases of antenatally diagnosed congenital diaphragmatic hernia: preliminary observations. Ultrasound Obstet Gynecol 1993;3:164-167.
303. van Eyck J, van der MK, Wladimiroff JW. Ductus arteriosus flow velocity modulation by fetal breathing movements as a measure of fetal lung development. Am J Obstet Gynecol 1990;163: 558-566.
304. Laudy JA, Tibboel D, Robben SG, et al. Prenatal prediction of pulmonary hypoplasia: clinical, biometric, and Doppler velocity correlates. Pediatrics 2002;109:250-258.
305. Vintzileos AM, Campbell WA, Rodis JF, et al. Comparison of six different ultrasonographic methods for predicting lethal fetal pulmonary hypoplasia. Am J Obstet Gynecol 1989;161:606-612.
306. Heling KS, Tennstedt C, Chaoui R, et al. Reliability of prenatal sonographic lung biometry in the diagnosis of pulmonary hypoplasia. Prenat Diagn 2001;21:649-657.
307. Fisk NM, Ronderos-Dumit D, Soliani A, et al. Diagnostic and therapeutic transabdominal amnioinfusion in oligohydramnios. Obstet Gynecol 1991;78:270-278.
308. Nakayama DK, Glick PL, Harrison MR, et al. Experimental pulmonary hypoplasia due to oligohydramnios and its reversal by relieving thoracic compression. J Pediatr Surg 1983;18:347-353.
309. Potter E. Bilateral renal agenesis. J Pediatr 1946;29:68.
310. Porter HJ. Pulmonary hypoplasia-size is not everything. Virchows Arch 1998;432.
311. Wenstrom KD. Pulmonary hypoplasia and deformations related to premature rupture of membranes. Obstet Gynecol Clin North Am 1992;19:397-408.
312. Tamura RK, Sabbagha RE, Depp R, et al. Diminished growth in fetuses born preterm after spontaneous labor or rupture of membranes. Am J Obstet Gynecol 1984;148:1105-1110.
313. Bukowski R, Gahn D, Denning J, Saade G. Impairment of growth in fetuses destined to deliver preterm. Am J Obstet Gynecol 2001;185:463-467.
314. Spinillo A, Montanari L, Sanpaolo P, et al. Fetal growth and infant neurodevelopmental outcome after preterm premature rupture of membranes. Obstet Gynecol 2004;103:1286-1293.
315. Blackwell S, Romero R, Chaiworapongsa T, et al. Maternal and fetal inflammatory responses in unexplained fetal death. J Matern Fetal Neonatal Med 2003;14:151-157.
316. Gerber S, Vardhana S, Meagher-Villemure K, et al. Association between fetal interleukin-1 receptor antagonist gene polymorphism and unexplained fetal death. Am J Obstet Gynecol 2005;193:1472-1477.
317. Reece EA, Chervenak FA, Moya FR, Hobbins JC. Amniotic fluid arborization: effect of blood, meconium, and pH alterations. Obstet Gynecol 1984;64:248-250.
318. Friedman ML, Mcelin TW. Diagnosis of ruptured fetal membranes. Clinical study and review of the literature. Am J Obstet Gynecol 1969;104:544-550.
319. Lodeiro JG, Hsieh KA, Byers JH, Feinstein SJ. The fingerprint, a false-positive fern test. Obstet Gynecol 1989;73:873-874.
320. McGregor JA, Johnson S. "Fig leaf" ferning and positive nitrazine testing: semen as a cause of misdiagnosis of premature rupture of membranes. Am J Obstet Gynecol 1985;151:1142-1143.
321. Brookes C, Shand K, Jones WR. A reevaluation of the ferning test to detect ruptured membranes. Aust NZ J Obstet Gynaecol 1986;26:260-264.
322. Rosemond RL, Lombardi SJ, Boehm FH. Ferning of amniotic fluid contaminated with blood. Obstet Gynecol 1990;75:338-340.
323. Bennett SL, Cullen JB, Sherer DM, Woods JR, Jr. The ferning and nitrazine tests of amniotic fluid between 12 and 41 weeks gestation. Am J Perinatol 1993;10:101-104.
324. Adoni A, Ben Chetrit A, Zacut D, et al. Prolongation of the latent period in patients with premature rupture of the membranes by avoiding digital examination. Int J Gynaecol Obstet 1990;32:19-21.
325. Lewis DF, Major CA, Towers CV, et al. Effects of digital vaginal examinations on latency period in preterm premature rupture of membranes. Obstet Gynecol 1992;80:630-634.
326. Schutte MF, Treffers PE, Kloosterman GJ, Soepatmi S. Management of premature rupture of membranes: the risk of vaginal examination to the infant. Am J Obstet Gynecol 1983;146:395-400.
327. Sukcharoen N, Vasuratna A. Effects of digital cervical examinations on duration of latency period, maternal and neonatal outcome in preterm premature rupture of membranes. J Med Assoc Thai 1993;76:203-209.
328. Munson LA, Graham A, Koos BJ, Valenzuela GJ. Is there a need for digital examination in patients with spontaneous rupture of the membranes? Am J Obstet Gynecol 1985;153:562-563.
329. Brown CL, Ludwiczak MH, Blanco JD, Hirsch CE. Cervical dilation: accuracy of visual and digital examinations. Obstet Gynecol 1993;81:215-216.
330. Morgan MA, de Veciana M, Rumney PJ, Schlinke S. Cervical assessment: visual or digital? J Perinatol 1996;16:103-106.
331. Smith RP. A technique for the detection of rupture of the membranes. A review and preliminary report. Obstet Gynecol 1976;48:172-176.
332. Gahl W, Kazina TR, Furmann D, et al. Diamine oxidase in the diagnosis of ruptured fetal membranes. Am J Obstet Gynecol 1969;104:544.
333. Huber JF, Bischof P, Extermann P, et al. Are vaginal fluid concentrations of prolactin, alpha-fetoprotein and human placental lactogen useful for diagnosing ruptured membranes? Br J Obstet Gynaecol 1983;90:1183-1185.
334. Koninckx PR, Trappeniers H, Van Assche FA. Prolactin concentration in vaginal fluid: a new method for diagnosing ruptured membranes. Br J Obstet Gynaecol 1981;88:607-610.
335. Phocas I, Sarandakou A, Kontoravdis A, et al. Vaginal fluid prolactin: a reliable marker for the diagnosis of prematurely ruptured membranes. Comparison with vaginal fluid alpha-fetoprotein and placental lactogen. Eur J Obstet Gynecol Reprod Biol 1989;31:133-141.
336. Gaucherand P, Guibaud S, Rudigoz RC, Wong A. Diagnosis of premature rupture of the membranes by the identification of alpha-feto-protein in vaginal secretions. Acta Obstet Gynecol Scand 1994;73:456-459.
337. Kishida T, Hirao A, Matsuura T, et al. Diagnosis of premature rupture of membranes with an improved alpha-fetoprotein monoclonal antibody kit. Clin Chem 1995;41:1500-1503.
338. Kishida T, Yamada H, Negishi H, et al. Diagnosis of preterm premature rupture of the membranes using a newly developed AFP monoclonal antibody test kit. Eur J Obstet Gynecol Reprod Biol 1995;58:67-72.
339. Lockwood CJ, Wein R, Chien D, et al. Fetal membrane rupture is associated with the presence of insulin-like growth factorbinding protein-1 in vaginal secretions. Am J Obstet Gynecol 1994;171:146-150.
340. Buyukbayrak EE, Turan C, Unal O, et al. Diagnostic power of the vaginal washing-fluid prolactin assay as an alternative method for the diagnosis of premature rupture of membranes. J Matern Fetal Neonatal Med 2004;15:120-125.
341. Esim E, Turan C, Unal O, et al. Diagnosis of premature rupture of membranes by identification of beta-HCG in vaginal washing fluid. Eur J Obstet Gynecol Reprod Biol 2003;107:37-40.
342. Erdemoglu E, Mungan T. Significance of detecting insulin-like growth factor binding protein-1 in cervicovaginal secretions: comparison with nitrazine test and amniotic fluid volume assessment. Acta Obstet Gynecol Scand 2004;83:622-626.
343. Anai T, Tanaka Y, Hirota Y, Miyakawa I. Vaginal fluid hCG levels for detecting premature rupture of membranes. Obstet Gynecol 1997;89:261-264.
344. Kishida T, Yamada H, Negishi H, et al. Diagnosis of premature rupture of the membranes in preterm patients, using an improved AFP kit: comparison with ROM-check and/or nitrazine test. Eur J Obstet Gynecol Reprod Biol 1996;69:77-82.
345. Atterbury JL, Groome LJ, Hoff C. Methods used to diagnose premature rupture of membranes: a national survey of 812 obstetric nurses. Obstet Gynecol 1998;92:384-389.
346. Lockwood CJ, Senyei AE, Dische MR, et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991;325:669-674.
347. Eriksen NL, Parisi VM, Daoust S, et al. Fetal fibronectin: a method for detecting the presence of amniotic fluid. Obstet Gynecol 1992;80:451-454.
348. Goldenberg RL, Mercer BM, Meis PJ, et al. The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth. NICHD Maternal Fetal Medicine Units Network. Obstet Gynecol 1996;87:643-648.
349. Greenhagen JB, Van Wagoner J, Dudley D, et al. Value of fetal fibronectin as a predictor of preterm delivery for a low-risk population. Am J Obstet Gynecol 1996;175:1054-1056.
350. Irion O, Matute S, Bischof P, Beguin F. Cervical oncofetal fibronectin in patients with false labor as a predictor of preterm delivery. Am J Obstet Gynecol 1996;394:384.
351. Leeson SC, Maresh MJ, Martindale EA, et al. Detection of fetal fibronectin as a predictor of preterm delivery in high risk asymptomatic pregnancies. Br J Obstet Gynaecol 1996;103:48-53.
352. Malak TM, Sizmur F, Bell SC, Taylor DJ. Fetal fibronectin in cer-vicovaginal secretions as a predictor of preterm birth. Br J Obstet Gynaecol 1996;103:648-653.
353. Morrison JC, Allbert JR, McLaughlin BN, et al. Oncofetal fibronectin in patients with false labor as a predictor of preterm delivery. Am J Obstet Gynecol 1993;168:538-542.
354. Nageotte MP, Casal D, Senyei AE. Fetal fibronectin in patients at increased risk for premature birth. Am J Obstet Gynecol 1994;170:20-25.
355. Rizzo G, Capponi A, Arduini D, et al. The value of fetal fibronectin in cervical and vaginal secretions and of ultrasonographic examination of the uterine cervix in predicting premature delivery for patients with preterm labor and intact membranes. Am J Obstet Gynecol 1996;175:1146-1151.
356. Atlay RD, Sutherst JR. Premature rupture of the fetal membranes confirmed by intra-amniotic injection of dye (Evans blue T-1824). Am J Obstet Gynecol 1970;108:993-994.
357. Diaz-Garzon J. Indigocarmine test of preterm rupture of membranes. Rev Columb Obstet Gynecol 1969;20:373.
358. Fujimoto S, Kishida T, Sagawa T, et al. Clinical usefulness of the dye-injection method for diagnosing premature rupture of the membranes in equivocal cases. J Obstet Gynaecol 1995;21:215-220.
359. Meyer BA, Gonik B, Creasy RK. Evaluation of phenazopyridine hydrochloride as a tool in the diagnosis of premature rupture of the membranes. Am J Perinatol 1991;8:297-299.
360. Cowett RM, Hakanson DO, Kocon RW, Oh W. Untoward neonatal effect of intraamniotic administration of methylene blue. Obstet Gynecol 1976;48:74S-75S.
361. McEnerney J, McEnerney L. Unfavourable neonatal outcomes after intraamniotic injection of methylene blue. Obstet Gynecol 1983;1983:351.
362. Troche BI. Methylene blue baby. N Engl J Med 1989;320:1756-1757.
363. Divon MY, Chamberlain PF, Sipos L, Platt LD. Underestimation of fetal weight in premature rupture of membranes. J Ultrasound Med 1984;3:529-531.
364. Ben Haroush A, Yogev Y, Bar J, et al. Accuracy of sonographi-cally estimated fetal weight in 840 women with different pregnancy complications prior to induction of labor. Ultrasound Obstet Gynecol 2004;23:172-176.
365. Edwards A, Goff J, Baker L. Accuracy and modifying factors of the sonographic estimation of fetal weight in a high-risk population. Aust NZ J Obstet Gynaecol 2001;41:187-190.
366. Romero R, Goncalves LF, Ghezzi F, et al. Amniocenteses. In: Fleischer AC, Manning FA, Jeanty P, Romero R, eds. Sonogra-phy in obstetrics and gynecology: principles and practice. Stamford, CT: Appleton & Lange, 1996.
367. Cotton DB, Gonik B, Bottoms SF. Conservative versus aggressive management of preterm rupture of membranes. A randomized trial of amniocentesis. Am J Perinatol 1984;1:322-324.
368. Shim SS, Romero R, Hong JS, et al. Clinical significance of intra-amniotic inflammation in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 2004;191:1339-1345.
369. Yoon BH, Romero R, Kim CJ, et al. Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity. Am J Obstet Gynecol 1995;172:960-970.
370. Jalava J, Mantymaa ML, Ekblad U, et al. Bacterial 16S rDNA polymerase chain reaction in the detection of intra-amniotic infection. Br J Obstet Gynaecol 1996;103:664-669.
371. Romero R, Gomez R, Nien JK, et al. Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery. Am J Obstet Gynecol 2004;191(6):S2.
372. Yeast JD, Garite TJ, Dorchester W. The risks of amniocentesis in the management of premature rupture of the membranes. Am J Obstet Gynecol 1984;149:505-508.
373. Shaver DC, Spinnato JA, Whybrew D, et al. Comparison of phospholipids in vaginal and amniocentesis specimens of patients with premature rupture of membranes. Am J Obstet Gynecol 1987;156:454-457.
374. Stedman CM, Crawford S, Staten E, Cherny WB. Management of preterm premature rupture of membranes: assessing amniotic fluid in the vagina for phosphatidylglycerol. Am J Obstet Gynecol 1981;140:34-38.
375. Brame RG, MacKenna J. Vaginal pool phospholipids in the management of premature rupture of membranes. Am J Obstet Gynecol 1983;145:992-1000.
376. Golde SH. Use of obstetric perineal pads in collection of amniotic fluid in patients with rupture of the membranes. Am J Obstet Gynecol 1983;146:710-712.
377. Estol PC, Poseiro JJ, Schwarcz R. Phosphatidylglycerol determination in the amniotic fluid from a pad placed over the vulva: a method for diagnosis of fetal lung maturity in cases of premature ruptured membranes. J Perinat Med 1992;20:65-71.
378. Lewis DF, Towers CV, Major CA, et al. Use of Amniostat-FLM in detecting the presence of phosphatidylglycerol in vaginal pool samples in preterm premature rupture of membranes. Am J Obstet Gynecol 1993;169:573-576.
379. Gluck L, Kulovich MV, Borer RC, Jr, Keidel WN. The interpretation and significance of the lecithin-sphingomyelin ratio in amniotic fluid. Am J Obstet Gynecol 1974;120:142-155.
380. Schumacher RE, Parisi VM, Steady HM, Tsao FH. Bacteria causing false positive test for phosphatidylglycerol in amniotic fluid. Am J Obstet Gynecol 1985;151:1067-1068.
381. Dombroski RA, MacKenna J, Brame RG. Comparison of amni-otic fluid lung maturity profiles in paired vaginal and amniocen-tesis specimens. Am J Obstet Gynecol 1981;140:461-464.
382. Goldstein AS, Mangurten HH, Libretti JV, Berman AM. Lecithin/sphingomyelin ratio in amniotic fluid obtained vagi-nally. Am J Obstet Gynecol 1980;138:232-233.
383. Sbarra AJ, Blake G, Cetrulo CL, et al. The effect of cervical/vaginal secretions on measurements of lecithin/sphin-gomyelin ratio and optical density at 650 nm. Am J Obstet Gynecol 1981;139:214-216.
384. Phillippe M, Acker D, Torday J, et al. The effects of vaginal contamination on two pulmonary phospholipid assays. J Reprod Med 1982;27:283-286.
385. Spinnato JA, Shaver DC, Bray EM, Lipshitz J. Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Obstet Gynecol 1987;69:196-201.
386. Mercer BM, Crocker LG, Boe NM, Sibai BM. Induction versus expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. Am J Obstet Gynecol 1993;169:775-782.
387. Vintzileos AM, Feinstein SJ, Lodeiro JG, et al. Fetal biophysical profile and the effect of premature rupture of the membranes. Obstet Gynecol 1986;67:818-823.
388. Vintzileos AM, Campbell WA, Nochimson DJ, Weinbaum PJ. The use of the nonstress test in patients with premature rupture of the membranes. Am J Obstet Gynecol 1986;155:149-153.
389. Zeevi D, Sadovsky E, Younis J, et al. Antepartum fetal heart rate characteristics in cases of premature rupture of membranes. Am J Perinatol 1988;5:260-263.
390. Vintzileos AM, Knuppel RA. Fetal biophysical assessment in premature rupture of the membranes. Clin Obstet Gynecol 1995;38:45-58.
391. Carroll SG, Papaioannou S, Nicolaides KH. Assessment of fetal activity and amniotic fluid volume in the prediction of intrauterine infection in preterm prelabor amniorrhexis. Am J Obstet Gynecol 1995;172:1427-1435.
392. Del Valle GO, Joffe GM, Izquierdo LA, et al. The biophysical profile and the nonstress test: poor predictors of chorioamnioni-tis and fetal infection in prolonged preterm premature rupture of membranes. Obstet Gynecol 1992;80:106-110.
393. Gauthier DW, Meyer WJ, Bieniarz A. Biophysical profile as a predictor of amniotic fluid culture results. Obstet Gynecol 1992;80:102-105.
394. Jackson DN, Lewis DF, Nageotte MP, Towers CV. Daily amnio-tic fluid index study in the management of preterm prolonged ruptured membranes: a prospective study. SPO Abstract 655. Am J Obstet Gynecol 1991;164:423.
395. Vintzileos AM, Campbell WA, Nochimson DJ, Weinbaum PJ. Degree of oligohydramnios and pregnancy outcome in patients with premature rupture of the membranes. Obstet Gynecol 1985;66:162-167.
396. Hadi HA, Hodson CA, Strickland D. Premature rupture of the membranes between 20 and 25 weeks' gestation: role of amnio-tic fluid volume in perinatal outcome. Am J Obstet Gynecol 1994;170:1139-1144.
397. Lao TT, Cheung VY. Expectant management of preterm prelabour rupture of membranes-the significance of oligohy-dramnios at presentation. Eur J Obstet Gynecol Reprod Biol 1993;48:87-91.
398. Scane TM, Hawkins DF. Antibacterial activity in human amni-otic fluid: dependence on divalent cations. Br J Obstet Gynaecol 1986;93:577-581.
399. Yoon BH, Kim YA, Romero R, et al. Association of oligohy-dramnios in women with preterm premature rupture of membranes with an inflammatory response in fetal, amniotic, and maternal compartments. Am J Obstet Gynecol 1999;181:784-788.
400. Smith CV, Greenspoon J, Phelan JP, Platt LD. Clinical utility of the nonstress test in the conservative management of women with preterm spontaneous premature rupture of the membranes. J Reprod Med 1987;32:1-4.
401. Kivikoski AI, Amon E, Vaalamo PO, et al. Effect of third-trimester premature rupture of membranes on fetal breathing movements: a prospective case-control study. Am J Obstet Gynecol 1988;159:1474-1477.
402. Roberts AB, Goldstein I, Romero R, Hobbins JC. Fetal breathing movements after preterm premature rupture of membranes. Am J Obstet Gynecol 1991;164:821-825.
403. Vintzileos AM, Campbell WA, Nochimson DJ, et al. The fetal biophysical profile in patients with premature rupture of the membranes-an early predictor of fetal infection. Am J Obstet Gynecol 1985;152:510-516.
404. Vintzileos AM, Campbell WA, Nochimson DJ, Weinbaum PJ. Fetal breathing as a predictor of infection in premature rupture of the membranes. Obstet Gynecol 1986;67:813-817.
405. Goldstein I, Romero R, Merrill S, et al. Fetal body and breathing movements as predictors of intraamniotic infection in preterm premature rupture of membranes. Am J Obstet Gynecol 1988;159:363-368.
406. Kitterman JA, Liggins GC, Clements JA, Tooley WH. Stimulation of breathing movements in fetal sheep by inhibitors of prostaglandin synthesis. J Dev Physiol 1979;1:453-466.
407. Thompson PJ, Greenough A, Nicolaides KH. Fetal breathing movements and prostaglandin levels in pregnancies complicated by premature rupture of the membranes. J Perinat Med 1992;20:209-213.
408. Manning FA, Morrison I, Lange IR, et al. Fetal assessment based on fetal biophysical profile scoring: experience in 12,620 referred high-risk pregnancies. I. Perinatal mortality by frequency and etiology. Am J Obstet Gynecol 1985;151:343-350.
409. Fleming AD, Salafia CM, Vintzileos AM, et al. The relationships among umbilical artery velocimetry, fetal biophysical profile, and placental inflammation in preterm premature rupture of the membranes. Am J Obstet Gynecol 1991;164:38-41.
410. Mercer B, Moretti M, Shaver D. Intensive antenatal testing for women with prolonged preterm premature rupture of the membranes. Abstract 420. Presented at 11th Annual Meeting of the Society of Perinatal Obstetricians, San Francisco, 1991.
411. Miller JM, Jr, Kho MS, Brown HL, Gabert HA. Clinical chorioamnionitis is not predicted by an ultrasonic biophysical profile in patients with premature rupture of membranes. Obstet Gynecol 1990;76:1051-1054.
412. Roberts AB, Goldstein I, Romero R, Hobbins JC. Comparison of total fetal activity measurement with the biophysical profile in predicting intra-amniotic infection in preterm premature rupture of membranes. Ultrasound Obstet Gynecol 1991;1:36-39.
413. Roussis P, Rosemond RL, Glass C, Boehm FH. Preterm premature rupture of membranes: detection of infection. Am J Obstet Gynecol 1991;165:1099-1104.
414. Vintzileos AM, Bors-Koefoed R, Pelegano JF, et al. The use of fetal biophysical profile improves pregnancy outcome in premature rupture of the membranes. Am J Obstet Gynecol 1987;157:236-240.
415. Devoe LD, Youssef AE, Croom CS, Watson J. Can fetal biophysical observations anticipate outcome in preterm labor or preterm rupture of membranes? Obstet Gynecol 1994;84:432-438.
416. Evans MI, Hajj SN, Devoe LD, et al. C-reactive protein as a predictor of infectious morbidity with premature rupture of membranes. Am J Obstet Gynecol 1980;138:648-652.
417. Farb HF, Arnesen M, Geistler P, Knox GE. C-reactive protein with premature rupture of membranes and premature labor. Obstet Gynecol 1983;62:49-51.
418. Fisk NM, Fysh J, Child AG, et al. Is C-reactive protein really useful in preterm premature rupture of the membranes? Br J Obstet Gynaecol 1987;94:1159-1164.
419. Hawrylyshyn P, Bernstein P, Milligan JE, et al. Premature rupture of membranes: the role of C-reactive protein in the prediction of chorioamnionitis. Am J Obstet Gynecol 1983;147: 240-246.
420. Ismail MA, Zinaman MJ, Lowensohn RI, Moawad AH. The significance of C-reactive protein levels in women with premature rupture of membranes. Am J Obstet Gynecol 1985;151:541-544.
421. Kurki T, Teramo K, Ylikorkala O, Paavonen J. -reactive protein in preterm premature rupture of the membranes. Arch Gynecol Obstet 1990;247:31-37.
422. Romem Y, Artal R. -reactive protein as a predictor for chorioamnionitis in cases of premature rupture of the membranes. Am J Obstet Gynecol 1984;150:546-550.
423. Yoon BH, Jun JK, Park KH, et al. Serum C-reactive protein, white blood cell count, and amniotic fluid white blood cell count in women with preterm premature rupture of membranes. Obstet Gynecol 1996;88:1034-1040.
424. DiNaro E, Ghezzi F, Raio L, et al. C-reactive protein in vaginal fluid of patients with preterm premature rupture of membranes. Acta Obstet Gynecol Scand 2003;82:1072-1079.
425. Thompson PJ, Greenough A, Davies E, Nicolaides KH. Fetal C-reactive protein. Early Hum Dev 1993;32:81-85.
426. Yoon BH, Romero R, Yang SH, et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomala-cia. Am J Obstet Gynecol 1996;174:1433-1440.
427. Fanaroff AA, Hack M. Periventricular leukomalacia-prospects for prevention. N Engl J Med 1999;341:1229-1231.
428. Hack M, Fanaroff AA. Outcomes of extremely immature infants-a perinatal dilemma. N Engl J Med 1993;329:1649-1650.
429. Gold RB, Goyert GL, Schwartz DB, et al. Conservative management of second-trimester post-amniocentesis fluid leakage. Obstet Gynecol 1989;74:745-747.
430. Hanson FW, Tennant FR, Zorn EM, Samuels S. Analysis of 2136 genetic amniocenteses: experience of a single physician. Am J Obstet Gynecol 1985;152:436-443.
431. NIH Consensus Development Panel on the Effect of Corticos-teroids for Fetal Maturation on Perinatal Outcomes. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995;273:413-418.
432. Mercer BM. Preterm premature rupture of the membranes: diagnosis and management. Clin Perinatol 2004;31:765-782, vi.
433. Simhan HN, Canavan TP. Preterm premature rupture of membranes: diagnosis, evaluation and management strategies. Br J Obstet Gynaecol 2005;112(Suppl. 1):32-37.
434. Mercer BM, Arheart KL. Antimicrobial therapy in expectant management of preterm premature rupture of the membranes. Lancet 1995;346:1271-1279.
435. Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group. Lancet 2001;357:979-988.
436. Amon E, Lewis SV, Sibai BM, et al. Ampicillin prophylaxis in preterm premature rupture of the membranes: a prospective randomized study. Am J Obstet Gynecol 1988;159:539-543.
437. Morales WJ, Angel JL, O'Brien WF, Knuppel RA. Use of ampi-cillin and corticosteroids in premature rupture of membranes: a randomized study. Obstet Gynecol 1989;73:721-726.
438. Johnston MM, Sanchez-Ramos L, Vaughn AJ, et al. Antibiotic therapy in preterm premature rupture of membranes: a randomized, prospective, double-blind trial. Am J Obstet Gynecol 1990;163:743-747.
439. Christmas JT, Cox SM, Andrews W, et al. Expectant management of preterm ruptured membranes: effects of antimicrobial therapy. Obstet Gynecol 1992;80:759-762.
440. McGregor JA, French JI, Seo K. Antimicrobial therapy in preterm premature rupture of membranes: results of a prospective, double-blind, placebo-controlled trial of erythromycin. Am J Obstet Gynecol 1991;165:632-640.
441. Kurki T, Hallman M, Zilliacus R, et al. Premature rupture of the membranes: effect of penicillin prophylaxis and long-term outcome of the children. Am J Perinatol 1992;9:11-16.
442. McCaul JF, Perry KG, Jr, Moore JL, Jr, et al. Adjunctive antibiotic treatment of women with preterm rupture of membranes or preterm labor. Int J Gynaecol Obstet 1992;38:19-24.
443. Mercer BM, Moretti ML, Prevost RR, Sibai BM. Erythromycin therapy in preterm premature rupture of the membranes: a prospective, randomized trial of 220 patients. Am J Obstet Gynecol 1992;166:794-802.
444. Owen J, Groome LJ, Hauth JC. Randomized trial of prophylactic antibiotic therapy after preterm amnion rupture. Am J Obstet Gynecol 1993;169:976-981.
445. Blanco JD, Iams J, Artal R, et al. Multicentre double-blind prospective randomized trial of ceftrizoxime versus placebo in women with preterm premature rupture of the membranes. Am J Obstet Gynecol 1993;168:378.
446. Lockwood CJ, Costigan K, Ghidini A, et al. Double-blind, placebo-controlled trial of piperacillin prophylaxis in preterm membrane rupture. Am J Obstet Gynecol 1993;169:970-976.
447. Ernest JM, Givner LB. A prospective, randomized, placebo-controlled trial of penicillin in preterm premature rupture of membranes. Am J Obstet Gynecol 1994;170:516-521.
448. Mercer B, Miodovnik M, Thurnau G, et al. A multi centre randomized masked trial of antibiotics vs placebo therapy after preterm premature rupture of the membranes (Abstract no. 6). Am J Obstet Gynecol 1996;174:304.
449. Mercer BM, Miodovnik M, Thurnau GR, et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. JAMA 1997;278:989-995.
450. Lovett SM, Weiss JD, Diogo MJ, et al. A prospective, doubleblind, randomized, controlled clinical trial of ampicillin-sulbactam for preterm premature rupture of membranes in women receiving antenatal corticosteroid therapy. Am J Obstet Gynecol 1997;176:1030-1038.
451. Kenyon S, Boulvain M, Neilson J. A systematic review of antibiotics for preterm rupture of membranes in pregnancy (PROM). 1st SGI International Summit: Preterm Birth; 2005:116.
452. Kenyon S, Boulvain M, Neilson J. Antibiotics for preterm rupture of the membranes: a systematic review. Obstet Gynecol 2004;104:1051-1057.
453. Brelje MC, Kaltreider DF. The use of vaginal antibiotics in premature rupture of the membranes. Am J Obstet Gynecol 1966;94:889.
454. Ogita S, Imanaka M, Matsumoto M, Hatanaka K. Premature rupture of the membranes managed with a new cervical catheter. Lancet 1984;1:1330-1331.
455. Romero R, Scioscia AL, Edberg SC, Hobbins JC. Use of par-enteral antibiotic therapy to eradicate bacterial colonization of amniotic fluid in premature rupture of membranes. Obstet Gynecol 1986;67:15S-17S.
456. Romero R, Hagay Z, Nores J, et al. Eradication of Ureaplasma urealyticum from the amniotic fluid with transplacental antibiotic treatment. Am J Obstet Gynecol 1992;166:618-620.
457. Harding JE, Pang J, Knight DB, Liggins GC. Do antenatal cor-ticosteroids help in the setting of preterm rupture of membranes? Am J Obstet Gynecol 2001;184:131-139.
458. Crowley P. Corticosteroids after prelabour rupture of membranes (revised May 5, 1994). In: Keirse MJ, Renfre MJ, Neilson JP, Crowther C, eds. Pregnancy and childbirth module. The Cochrane Pregnancy and Childbirth Database. The Cochrane Collaboration, Issue 2 (available from BMJ Publishing Group, London). Oxford, UK, 1995.
459. Crowley P. Corticosteroids + induction of labour after PROM preterm (revised April 22, 1993). In: Keirse MJ, Renfre MJ, Neilson JP, Crowther C, eds. Pregnancy and childbirth module. The Cochrane Pregnancy and Childbirth Database. The Cochrane Collaboration, Issue 2 (available from BMJ Publishing Group, London). Oxford, UK, 1995.
460. Leitich H, Egarter C, Reisenberger K, et al. Concomitant use of glucocorticoids: a comparison of two metaanalyses on antibiotic treatment in preterm premature rupture of membranes. Am J Obstet Gynecol 1998;178:899-908.
461. Guinn DA, Atkinson MW, Sullivan L, et al. Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery: a randomized controlled trial. JAMA 2001;286:1581-1587.
462. Jobe AH, Wada N, Berry LM, et al. Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. Am J Obstet Gynecol 1998;178:880-885.
463. Dirnberger DR, Yoder BA, Gordon MC. Single versus repeated-course antenatal corticosteroids: outcomes in singleton and multiple-gestation pregnancies. Am J Perinatol 2001;18:267.
464. French NP, Hagan R, Evans SF, et al. Repeated antenatal corti-costeroids: size at birth and subsequent development. Am J Obstet Gynecol 1999;180:114-121.
465. Dunlop PD, Crowley PA, Lamont RF, Hawkins DF. Preterm ruptured membranes, no contractions. J Obstet Gynecol 1986;7:92.
466. Levy DL, Warsof SL. Oral ritodrine and preterm premature rupture of membranes. Obstet Gynecol 1985;66:621-623.
467. Christensen KK, Ingemarsson I, Leideman T, et al. Effect of rito-drine on labor after premature rupture of the membranes. Obstet Gynecol 1980;55:187-190.
468. Garite TJ, Keegan KA, Freeman RK, Nageotte MP. A randomized trial of ritodrine tocolysis versus expectant management in patients with premature rupture of membranes at 25 to 30 weeks of gestation. Am J Obstet Gynecol 1987;157:388-393.
469. Matsuda Y, Ikenoue T, Hokanishi H. Premature rupture of the membranes-aggressive versus conservative approach: effect of tocolytic and antibiotic therapy. Gynecol Obstet Invest 1993;36:102-107.
470. Weiner CP, Renk K, Klugman M. The therapeutic efficacy and cost-effectiveness of aggressive tocolysis for premature labor associated with premature rupture of the membranes. Am J Obstet Gynecol 1988;159:216-222.
471. Decavalas G, Mastrogiannis D, Papadopoulos V, Tzingounis V. Short-term versus long-term prophylactic tocolysis in patients with preterm premature rupture of membranes. Eur J Obstet Gynecol Reprod Biol 1995;59:143-147.
472. Harger JH. Comparison of success and morbidity in cervical cerclage procedures. Obstet Gynecol 1980;56:543-548.
473. Yeast JD, Garite TR. The role of cervical cerclage in the management of preterm premature rupture of the membranes. Am J Obstet Gynecol 1988;158:106-110.
474. Blickstein I, Katz Z, Lancet M, Molgilner BM. The outcome of pregnancies complicated by preterm rupture of the membranes with and without cerclage. Int J Gynaecol Obstet 1989;28:237-242.
475. Goldman JM, Greene MF, Tuomala R, et al. Outcome of expectant management in preterm premature rupture of membranes with cervical cerclage in place. Abstract 139. Presented at the Tenth Annual Meeting of the Society of Perinatal Obstetricians, Houston, Texas, 1990.
476. Ludmir J, Bader T, Chen L, et al. Poor perinatal outcome associated with retained cerclage in patients with premature rupture of membranes. Obstet Gynecol 1994;84:823-826.
477. McElrath TF, Norwitz ER, Lieberman ES, Heffner LJ. Perinatal outcome after preterm premature rupture of membranes with in situ cervical cerclage. Am J Obstet Gynecol 2002;187:1147-1152.
478. ACOG Technical Bulletin No. 15. Premature rupture of the membranes. Washington, DC: ACOG, 1988.
479. Carlan SJ, O'Brien WF, Parsons MT, Lense JJ. Preterm premature rupture of membranes: a randomized study of home versus hospital management. Obstet Gynecol 1993;81:61-64.
480. Philipson EH, Hoffman DS, Hansen GO, Ingardia CJ. Preterm premature rupture of membranes: experience with latent periods in excess of seven days. Am J Perinatol 1994;11:416-419.
481. Curet LB, Rao AV, Zachman RD, et al. Association between ruptured membranes, tocolytic therapy, and respiratory distress syndrome. Am J Obstet Gynecol 1984;148:263-268.
482. Ustun C, Kokcu A, Cil E, Kandemir B. Relationship between endomyometritis and the duration of premature membrane rupture. J Matern Fetal Med 1998;7:243-246.
483. McElrath TF, Allred EN, Leviton A. Prolonged latency after preterm premature rupture of membranes: an evaluation of his-tologic condition and intracranial ultrasonic abnormality in the neonate born at < 28 weeks of gestation. Am J Obstet Gynecol 2003;189:794-798.
484. Cox SM, Leveno KJ. Intentional delivery versus expectant management with preterm ruptured membranes at 30-34 weeks' gestation. Obstet Gynecol 1995;86:875-879.
485. Lieman JM, Brumfield CG, Carlo W, Ramsey PS. Preterm premature rupture of membranes: is there an optimal gestational age for delivery? Obstet Gynecol 2005;105:12-17.
486. Taylor J, Garite TJ. Premature rupture of membranes before fetal viability. Obstet Gynecol 1984;64:615-620.
487. Moretti M, Sibai BM. Maternal and perinatal outcome of expectant management of premature rupture of membranes in the midtrimester. Am J Obstet Gynecol 1988;159:390-396.
488. Major CA, Kitzmiller JL. Perinatal survival with expectant management of midtrimester rupture of membranes. Am J Obstet Gynecol 1990;163:838-844.
489. Beydoun SN, Yasin SY. Premature rupture of the membranes before 28 weeks: conservative management. Am J Obstet Gynecol 1986;155:471-479.
490. Bengtson JM, VanMarter LJ, Barss VA, et al. Pregnancy outcome after premature rupture of the membranes at or before 26 weeks' gestation. Obstet Gynecol 1989;73:921-927.
491. Hibbard JU, Hibbard MC, Ismail M, Arendt E. Pregnancy outcome after expectant management of premature rupture of the membranes in the second trimester. J Reprod Med 1993;38:945-951.
492. Morales WJ, Talley T. remature rupture of membranes at < 25 weeks: a management dilemma. Am J Obstet Gynecol 1993;168: 503-507.
493. Fortunato SJ, Welt SI, Eggleston MK, Jr, Bryant EC. Active expectant management in very early gestations complicated by premature rupture of the fetal membranes. J Reprod Med 1994;39:13-16.
494. Rib DM, Sherer DM, Woods JR, Jr. Maternal and neonatal outcome associated with prolonged premature rupture of membranes below 26 weeks' gestation. Am J Perinatol 1993;10: 369-373.
495. David J, Permezel M. Pregnancy outcomes following preterm premature rupture of the membranes at less than 26 weeks' gestation. Aust NZ J Obstet Gynaecol 1992;32:120.
496. Mercer BM. Management of premature rupture of membranes before 26 weeks' gestation. Obstet Gynecol Clin North Am 1992;19:339-351.
497. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists, No. 1. Washington, DC: ACOG; 1998:586.
498. Healy AJ, Veille JC, Sciscione A, et al. The timing of elective delivery in preterm premature rupture of the membranes: a survey of members of the Society of Maternal-Fetal Medicine. Am J Obstet Gynecol 2004;190:1479-1481.
499. Strong TH, Jr. Amnioinfusion with preterm, premature rupture of membranes. Clin Perinatol 1992;19:399-409.
500. Gabbe SG, Ettinger BB, Freeman RK, Martin CB. Umbilical cord compression associated with amniotomy: laboratory observations. Am J Obstet Gynecol 1976;126:353-355.
501. Moberg LJ, Garite TJ, Freeman RK. Fetal heart rate patterns and fetal distress in patients with preterm premature rupture of membranes. Obstet Gynecol 1984;64:60-64.
502. Miyazaki FS, Taylor NA. Saline amnioinfusion for relief of variable or prolonged decelerations. A preliminary report. Am J Obstet Gynecol 1983;146:670-678.
503. Miyazaki FS, Nevarez F. Saline amnioinfusion for relief of repetitive variable decelerations: a prospective randomized study. Am J Obstet Gynecol 1985;153:301-306.
504. Nageotte MP, Freeman RK, Garite TJ, Dorchester W. Prophylactic intrapartum amnioinfusion in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 1985; 153:557-562.
505. Hofmeyr GJ. Amnioinfusion: a question of benefits and risks. Br J Obstet Gynaecol 1992;99:449-451.
506. Wenstrom KD, Andrews WW, Maher JE. Prevalence and complications associated with amnioinfusion. Am J Obstet Gynecol 1994;170:341.
507. Fraser WD, Hofmeyr J, Lede R, et al. Amnioinfusion for the prevention of the meconium aspiration syndrome. N Engl J Med 2005;353:909-917.
508. Tranquilli AL, Giannubilo SR, Bezzeccheri V, Scagnoli C. Transabdominal amnioinfusion in preterm premature rupture of membranes: a randomised controlled trial. Br J Obstet Gynaecol 2005;112:759-763.
509. Gembruch U, Hansmann M. Artificial instillation of amniotic fluid as a new technique for the diagnostic evaluation of cases of oligohydramnios. Prenat Diagn 1988;8:33-45.
510. Chua S, Arulkumaran S, Yap C, et al. Premature rupture of membranes in nulliparas at term with unfavorable cervices: a doubleblind randomized trial of prostaglandin and placebo. Obstet Gynecol 1995;86:550-554.
511. Chung T, Rogers MS, Gordon H, Chang A. Prelabour rupture of the membranes at term and unfavourable cervix; a randomized placebo-controlled trial on early intervention with intravaginal prostaglandin E2 gel. Aust NZ J Obstet Gynaecol 1992;32:25-27.
512. Duff P, Huff RW, Gibbs RS. Management of premature rupture of membranes and unfavorable cervix in term pregnancy. Obstet Gynecol 1984;63:697-702.
513. Ekman-Ordeberg G, Uldbjerg N, Ulmsten U. Comparison of intravenous oxytocin and vaginal prostaglandin E2 gel in women with unripe cervixes and premature rupture of the membranes. Obstet Gynecol 1985;66:307-310.
514. Gonen R, Samberg I, Degani S. Intracervical prostaglandin E2 for induction of labor in patients with premature rupture of membranes and an unripe cervix. Am J Perinatol 1994;11: 436-438.
515. Grant JM, Serle E, Mahmood T, et al. Management of prelabour rupture of the membranes in term primigravidae: report of a randomized prospective trial. Br J Obstet Gynaecol 1992;99:557-562.
516. Hagskog K, Nisell H, Sarman I, Westgren M. Conservative ambulatory management of prelabor rupture of the membranes at term in nulliparous women. Acta Obstet Gynecol Scand 1994;73:765-769.
517. Hannah ME, Ohlsson A, Farine D, et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. TERMPROM Study Group. N Engl J Med 1996;334:1005-1010.
518. Hjertberg R, Hammarstrom M, Moberger B, et al. Premature rupture of the membranes (PROM) at term in nulliparous women with a ripe cervix. A randomized trial of 12 or 24 hours of expectant management. Acta Obstet Gynecol Scand 1996;75:48-53.
519. Ladfors L, Mattsson LA, Eriksson M, Fall O. A randomised trial of two expectant managements of prelabour rupture of the membranes at 34 to 42 weeks. Br J Obstet Gynaecol 1996;103:755-762.
520. Mahmood TA, Dick MJ, Smith NC, Templeton AA. Role of prostaglandin in the management of prelabour rupture of the membranes at term. Br J Obstet Gynaecol 1992;99:112-117.
521. Mahmood TA, Dick MJ. A randomized trial of management of pre-labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstet Gynecol 1995;85:71-74.
522. Malik N, Gittens L, Gonzalez D, et al. Clinical amnionitis and endometritis in patients with premature rupture of membranes: endocervical prostaglandin E2 gel versus oxytocin for induction of labor. Obstet Gynecol 1996;88:540-543.
523. Morales WJ, Lazar AJ. Expectant management of rupture of membranes at term. South Med J 1986;79:955-958.
524. Mozurkewich E, Wolf F. Premature rupture of membranes at term: a meta-analysis of three management schemes. Obstet Gynecol 1997;89:1035-1043.
525. Natale R, Milne JK, Campbell MK, et al Management of premature rupture of membranes at term: randomized trial. Am J Obstet Gynecol 1994;171:936-939.
526. Ngai SW, To WK, Lao T, Ho PC. Cervical priming with oral misoprostol in pre-labor rupture of membranes at term. Obstet Gynecol 1996;87:923-926.
527. Ray DA, Garite TJ. Prostaglandin E2 for induction of labor in patients with premature rupture of membranes at term. Am J Obstet Gynecol 1992;166:836-843.
528. Rydhstrom H, Ingemarsson I. No benefit from conservative management in nulliparous women with premature rupture of the membranes (PROM) at term. A randomized study. Acta Obstet Gynecol Scand 1991;70:543-547.
529. Rymer J, Parker A. A comparison of Syntocinon infusion with prostaglandin vaginal pessaries when spontaneous rupture of the membranes occurs without labour after 34 weeks gestation. Aust NZ J Obstet Gynaecol 1992;32:22-24.
530. Shalev E, Schantz A, Wahlin A, et al. Management of prelabor rupture of membranes at term. A randomized study. Acta Obstet Gynecol Scand 1993;72:627.
531. Shalev E, Peleg D, Eliyahu S, Nahum Z. Comparison of 12-and 72-hour expectant management of premature rupture of membranes in term pregnancies. Obstet Gynecol 1995;85:766-768.
532. Wagner MV, Chin VP, Peters CJ, et al. A comparison of early and delayed induction of labor with spontaneous rupture of membranes at term. Obstet Gynecol 1989;74:93-97.
533. Zlatnik FJ. Management of premature rupture of membranes at term. Obstet Gynecol Clin North Am 1992;19:353-364.
534. Tan BP, Hannah ME. Oxytocin for prelabour rupture of membranes at or near term. Cochrane Database Syst Rev 2000;CD000157.
535. Lin MG, Nuthalapaty FS, Carver AR, et al. Misoprostol for labor induction in women with term premature rupture of membranes: a meta-analysis. Obstet Gynecol 2005;106:593-601.
536. Dare MR, Middleton P, Crowther CA, et al. Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more). Cochrane Database Syst Rev 2006;1:CD005302.
537. Hannah ME, Hodnett ED, Willan A, et al. Prelabor rupture of the membranes at term: expectant management at home or in hospital? The TermPROM Study Group. Obstet Gynecol 2000;96:533-538.
538. Genz HJ. [Treatment of premature rupture of the fetal membranes by means of fibrin adhesion]. Med Welt 1979;30:1557-1559.
539. Kurz C, Hick A. Fibrin sealing: an advanced therapy in dealing with premature rupture of membranes. J Perinat Med 1982;66.
540. Baumgarten K, Moser S. The technique of fibrin adhesion for premature rupture of the membranes during pregnancy. J Perinat Med 1986;14:43-49.
541. Uchide K, Terada S, Hamasaki H, et al. Intracervical fibrin instillation as an adjuvant to treatment for second trimester rupture of membranes. Arch Gynecol Obstet 1994;255:95-98.
542. Catalano A, Zardini E. [Premature rupture of the membranes. Spontaneous course of the event and the therapeutic approach with a human fibrin glue]. Minerva Ginecol 1994;46:675-680.
543. Sciscione AC, Manley JS, Pollock M, et al. Intracervical fibrin sealants: a potential treatment for early preterm premature rupture of the membranes. Am J Obstet Gynecol 2001;184: 368-373.
544. Quintero RA, Romero R, Dzieczkowski J, et al. Sealing of ruptured amniotic membranes with intra-amniotic platelet-cryoprecipitate plug. Lancet 1996;347:1117.
545. Quintero RA. Treatment of previable premature ruptured membranes. Clin Perinatol 2003;30:573-589.
546. Vaitkiene D, Bergstrom S. Management of amniocentesis in women with oligohydramnios due to membrane rupture: evaluation of a cervical adapter. Gynecol Obstet Invest 1995;40:28-31.
547. O'Brien JM, Barton JR, Milligan DA. An aggressive interven-tional protocol for early midtrimester premature rupture of the membranes using gelatin sponge for cervical plugging. Am J Obstet Gynecol 2002;187:1143-1146.
548. Quintero RA. New horizons in the treatment of preterm premature rupture of membranes. Clin Perinatol 2001;28:861-875.
549. Ferrand PE, Fujimoto T, Chennathukuzhi V, et al. The CARD15 29361nsC mutation and TLR4 896 A→G polymorphism in African Americans and risk of preterm premature rupture of membranes (PPROM). Mol Hum Reprod 2002;8:1031-1034.
550. Kalish RB, Vardhana S, Gupta M, et al. Interleukin-1 receptor antagonist gene polymorphism and multifetal pregnancy outcome. Am J Obstet Gynecol 2003;189:911-914.
551. Kalish RB, Vardhana S, Gupta M, et al. Polymorphisms in the tumor necrosis factor-alpha gene at position-308 and the inducible 70 kd heat shock protein gene at position +1267 in multifetal pregnancies and preterm premature rupture of fetal membranes. Am J Obstet Gynecol 2004;191:1368-1374.
552. Kalish RB, Nguyen DP, Vardhana S, et al. A single nucleotide A→G polymorphism at position-670 in the Fas gene promoter: relationship to preterm premature rupture of fetal membranes in multifetal pregnancies. Am J Obstet Gynecol 2005;192:208-212.
553. Annells MF, Hart PH, Mullighan CG, et al. Interleukins-1,-4,-6,-10, tumor necrosis factor, transforming growth factor-beta, FAS, and mannose-binding protein C gene polymorphisms in Australian women: risk of preterm birth. Am J Obstet Gynecol 2004;191:2056-2067.
554. Fuks A, Parton LA, Polavarapu S, et al. Polymorphism of Fas and Fas ligand in preterm premature rupture of membranes in singleton pregnancies. Am J Obstet Gynecol 2005;193:1132-1136.
555. Hussey MJ, Levy ES, Pombar X, et al. Evaluating rapid diagnostic tests of intra-amniotic infection: Gram stain, amniotic fluid glucose level, and amniotic fluid to serum glucose level ratio. Am J Obstet Gynecol 1998;179:650-656.
556. Maymon E, Romero R, Chaiworapongsa T, et al. Value of amni-otic fluid neutrophil collagenase concentrations in preterm premature rupture of membranes. Am J Obstet Gynecol 2001;185: 1143-1148.
557. Romero R, Ghidini A, Bahado-Singh R. Premature rupture of the membranes. In: Reece E, Hobbins J, Mahoney M, Petrie R, eds. Medicine of the fetus and mother. Philadelphia: Lippincott; 1992:1430-1468.
558. Goldstein I, Copel J, Hobbins J. Fetal behavior in preterm premature rupture of the membranes. Clin Perinatol 1989;16:735.
559. Asrat T, Nageote M, Garite T, et al. Gram stain results from amniocentesis in patients with preterm premature rupture of the membranes. Am J Obstet Gynecol 1991;163:887.
560. Romero R, Gomez R, Galasso M, et al. Is oligohydramnios a risk factor for infection in term premature rupture of membranes? Ultrasound Obstet Gynecol 1994;4:95-100.